https://hospitalpharmacyeurope.com/in-depth/views/taking-a-stand-against-gastric-disease/ 2024-08-16T14:14:15+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/10/UEG-gastric-disease.jpg https://hospitalpharmacyeurope.com/wp-content/uploads/2019/10/UEG-Whitebook-Oesophageal-and-gastric-cancer-1.png https://hospitalpharmacyeurope.com/clinical-zones/24977-2/ 2024-08-16T14:15:43+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/10/Senior-exercise-1.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/accelerating-the-diagnosis-of-brain-cancer/ 2024-08-16T14:15:56+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/10/Brain-cancer.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/real-world-data-to-support-the-use-of-genomic-testing-in-cancer-therapy/ 2024-08-16T14:17:09+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/07/mi-48351.jpeg https://hospitalpharmacyeurope.com/clinical-zones/a-silent-epidemic/ 2024-08-16T14:24:51+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/09/Osteoporosis.jpg https://hospitalpharmacyeurope.com/clinical-zones/rheumatology/sc-biosimilar-has-the-potential-to-enhance-treatment-options-in-ra/ 2024-08-16T14:26:21+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/09/CTP13-1047719428.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/first-tumour-agnostic-treatment-licensed-in-europe/ 2024-08-16T14:27:01+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/09/Tumour-agnostic.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/results-from-the-caspian-trial-presented-at-wclc-2019/ 2024-08-16T14:27:26+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/09/Caspian.jpg https://hospitalpharmacyeurope.com/clinical-zones/neurology/siponimod-may-preserve-mobility-and-brain-volume-in-secondary-progressive-multiple-sclerosis/ 2024-08-16T14:28:43+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/09/Siponomid.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/nivolumab-increases-overall-survival-five-fold-in-lung-cancer-patients/ 2024-08-16T14:29:26+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/09/Nivolumab.jpg https://hospitalpharmacyeurope.com/clinical-zones/mental-health/aspire-i-and-ii-trial-data-presented-at-ecnp/ 2024-08-16T14:30:16+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/09/Esketamine.jpg https://hospitalpharmacyeurope.com/clinical-zones/gastroenterology/european-commission-approves-expanded-use-of-ustekinumab/ 2024-08-16T14:30:57+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/09/Stelara.jpg https://hospitalpharmacyeurope.com/clinical-zones/paediatrics/mobile-app-in-managing-uncontrolled-asthma/ 2024-08-16T14:33:24+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/09/Mobile.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/antibody-drug-increases-success-of-cancer-immunotherapies/ 2024-08-16T15:19:25+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/08/Cropped626241966.jpg https://hospitalpharmacyeurope.com/clinical-zones/neurology/uniting-to-tackle-motor-neurone-disease/ 2024-08-16T15:19:59+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/08/MND.jpg https://hospitalpharmacyeurope.com/news/helapet-announce-launch-of-new-sterile-neutral-detergent-spray/ 2024-08-16T15:21:00+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/08/Helapet_product_965x500px.jpg https://hospitalpharmacyeurope.com/wp-content/uploads/2019/08/Neutral_Detergent_Spray_in_hand_PLAIN.jpg https://hospitalpharmacyeurope.com/clinical-zones/rheumatology/researchers-identify-key-mechanism-linked-to-neuropsychiatric-lupus/ 2024-08-16T15:22:02+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/08/Neurolupus.jpg https://hospitalpharmacyeurope.com/clinical-zones/rheumatology/joint-lubricating-fluid-plays-key-role-in-osteoarthritic-pain/ 2024-08-16T15:22:25+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/08/Osteo.jpg https://hospitalpharmacyeurope.com/news/safety/new-iv-connector-products-announced/ 2024-08-16T15:24:12+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/08/Medidose-red.jpg https://hospitalpharmacyeurope.com/wp-content/uploads/2019/08/Medidose-red.jpg https://hospitalpharmacyeurope.com/wp-content/uploads/2019/08/Medidose-yellow.jpg https://hospitalpharmacyeurope.com/clinical-zones/dermatology/dupixent-hits-endpoints-in-phase-iii-paediatric-trial/ 2024-08-16T15:25:51+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/08/Dupixent.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/glargine-or-liraglutide-with-metformin-best-combination-for-glycated-haemoglobin-target/ 2024-08-16T15:25:59+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/09/Glargine-or-liraglutide-with-metformin-best-combination-for-glycated-haemoglobin-target.jpg https://hospitalpharmacyeurope.com/clinical-zones/emergency-and-critical-care/modified-paracetamol-overdose-protocol-leads-to-reduction-in-hospital-length-of-stay/ 2024-08-16T15:27:45+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/09/Modified-paracetamol-overdose-protocol-leads-to-reduction-in-hospital-length-of-stay.jpg https://hospitalpharmacyeurope.com/clinical-zones/emergency-and-critical-care/iv-paracetamol-provides-clinically-equivalent-acute-pain-relief-to-hydromorphone-for-older-adults-in-ed/ 2024-08-16T15:28:57+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/09/IV-paracetamol-provides-clinically-equivalent-acute-pain-relief-to-hydromorphone-for-older-adults-in-ED.jpg https://hospitalpharmacyeurope.com/clinical-zones/paediatrics/r21-matrix-m-vaccine-protects-against-malaria-in-children-over-2-year-period/ 2024-08-16T15:30:05+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/09/R21-Matrix-M-vaccine-protects-against-malaria-in-children-over-2-year-period.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/nice-recommends-additional-treatment-option-for-people-with-early-breast-cancer/ 2024-08-16T15:30:59+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/08/Neratinib.jpg https://hospitalpharmacyeurope.com/clinical-zones/dermatology/multiple-genes-affect-risk-of-asthma-hay-fever-and-eczema/ 2024-08-16T15:32:08+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/08/DNA.jpg https://hospitalpharmacyeurope.com/clinical-zones/neurology/cgrp-mab-effective-for-treatment-of-migraine-in-patients-with-comorbid-depression/ 2024-08-16T15:32:36+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/09/CGRP-mAb-effective-for-treatment-of-migraine-in-patients-with-comorbid-depression.jpg https://hospitalpharmacyeurope.com/in-depth/views/expert-view-why-are-allergies-on-the-rise/ 2024-08-16T15:32:38+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/08/Fassio.jpg https://hospitalpharmacyeurope.com/clinical-zones/neurology/positive-real-world-data-from-the-pearl-study-in-migraine-prevention-announced/ 2024-08-16T15:33:19+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/09/Positive-real-world-data-from-the-PEARL-study-in-migraine-prevention-announced.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/shrinking-brain-tumours-and-opening-the-door-for-targeted-cancer-therapies/ 2024-08-16T15:35:20+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/08/GBM2.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/researchers-make-immunotherapy-work-for-treatment-resistant-lymphoma/ 2024-08-16T15:35:34+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/08/Lymphoma.jpg https://hospitalpharmacyeurope.com/clinical-zones/gastroenterology/scottish-capital-is-global-hotspot-for-inflammatory-bowel-disease-rates/ 2024-08-16T15:36:20+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/08/Edinburgh.jpg https://hospitalpharmacyeurope.com/clinical-zones/medicinal-cannabis-reduces-use-of-opiate-based-painkillers/ 2024-08-16T15:37:34+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/10/Medicinal-cannabis-reduces-use-of-opiate-based-painkillers.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/offer-daily-aspirin-to-those-with-inherited-genetic-condition-to-reduce-risk-of-cancer/ 2024-08-16T15:38:00+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/08/Aspirin.jpg https://hospitalpharmacyeurope.com/clinical-zones/mental-health/mindfulness-based-stress-reduction-non-inferior-to-escitalopram-for-anxiety-disorders/ 2024-08-16T15:38:39+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/11/Mindfulness-based-stress-reduction-no-inferior-to-escitalopram-for-anxiety-disorders.gif https://hospitalpharmacyeurope.com/clinical-zones/respiratory/phase-iii-quartz-study-meets-primary-and-key-secondary-endpoints/ 2024-08-16T15:40:36+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/07/mi-48377.jpeg https://hospitalpharmacyeurope.com/clinical-zones/significant-placebo-effect-cannabinoid-pain-management-clinical-trials/ 2024-08-16T15:40:51+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/12/Significant-placebo-effect-cannabinoid-pain-management-clinical-trials.gif https://hospitalpharmacyeurope.com/clinical-zones/oncology/stem-cell-differences-could-explain-why-women-are-more-likely-to-develop-adrenal-cancer/ 2024-08-16T15:41:10+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/07/mi-48376.jpeg https://hospitalpharmacyeurope.com/clinical-zones/oncology/using-3d-to-test-personalised-cancer-treatments-in-five-days/ 2024-08-16T15:42:09+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/07/mi-48374.jpeg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/weekly-pharmacy-visits-boost-drug-adherence-and-quality-of-life-in-heart-failure-patients/ 2024-08-16T15:42:40+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/07/mi-48373.jpeg https://hospitalpharmacyeurope.com/clinical-zones/oncology/how-molecular-escorts-help-prevent-cancer/ 2024-08-16T15:44:30+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/07/mi-48375.jpeg https://hospitalpharmacyeurope.com/news/nice-issues-final-guidance-for-inotersen-for-hattr-amyloidosis/ 2024-08-16T15:45:45+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/07/mi-48371.jpeg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/inhaled-combination-treatment-shows-significant-improvements-over-current-standard-of-care/ 2024-08-16T15:47:17+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/07/mi-48370.jpeg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/women-less-likely-to-be-resuscitated-and-survive-a-cardiac-arrest-than-men/ 2024-08-16T15:47:46+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/07/mi-48368.jpeg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/expert-consensus-published-on-use-of-imaging-to-guide-heart-attack-treatment/ 2024-08-16T15:48:17+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/07/mi-48369.jpeg https://hospitalpharmacyeurope.com/news/record-number-of-patients-benefit-as-clinical-trial-participants-soar-across-england/ 2024-08-16T15:49:06+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/07/mi-48365.jpeg https://hospitalpharmacyeurope.com/clinical-zones/oncology/what-are-the-neurological-side-effects-of-car-t-cell-therapy/ 2024-08-16T15:50:30+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/07/mi-48367.jpeg https://hospitalpharmacyeurope.com/news/gphc-weighing-up-combining-british-pre-reg-assessment-with-northern-irelands/ 2024-08-16T15:51:09+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/07/mi-48366.jpeg https://hospitalpharmacyeurope.com/clinical-zones/oncology/new-strategy-of-reprogramming-regulatory-t-cells-may-improve-cancer-therapies/ 2024-08-16T15:51:52+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/07/mi-48364.jpeg https://hospitalpharmacyeurope.com/clinical-zones/oncology/liquid-biopsy-could-identify-cancer-patients-at-risk-of-metastatic-disease/ 2024-08-16T15:52:37+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/07/mi-48363.jpeg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/glucosamine-supplement-could-lower-heart-disease-risk-study-shows/ 2024-08-16T15:53:16+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/07/mi-48362.jpeg https://hospitalpharmacyeurope.com/clinical-zones/neurology/nice-recommends-ocrelizumab-following-manufacturer-and-nhs-lower-price-agreement/ 2024-08-16T15:54:13+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/07/mi-48361.jpeg https://hospitalpharmacyeurope.com/clinical-zones/oncology/scientists-discover-source-for-counteracting-drug-resistance-in-tumour-cells/ 2024-08-16T15:56:15+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/08/Oncology-1.jpg https://hospitalpharmacyeurope.com/news/no-deal-brexit-could-cause-six-months-meds-supply-problems-at-anglo-french-border-2/ 2024-08-16T15:57:41+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2002/09/HPE-european-community.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/first-lung-map-uncovers-new-insights-into-asthma/ 2024-08-16T15:58:41+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/07/mi-48400.jpeg https://hospitalpharmacyeurope.com/clinical-zones/gastroenterology/new-standards-raise-the-bar-for-ibd-care/ 2024-08-16T15:58:59+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/07/mi-48399.jpeg https://hospitalpharmacyeurope.com/clinical-zones/gastroenterology/research-highlights-possible-targets-to-help-tackle-crohns-disease/ 2024-08-16T15:59:11+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/07/mi-48398.jpeg https://hospitalpharmacyeurope.com/clinical-zones/rheumatology/new-data-demonstrate-impact-of-emapalumab-in-patients-with-macrophage-activation-syndrome/ 2024-08-16T15:59:39+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/07/mi-48397.jpeg https://hospitalpharmacyeurope.com/clinical-zones/oncology/lynparza-approved-for-first-line-maintenance-treatment-of-brca-mutated-advanced-ovarian-cancer/ 2024-08-16T16:00:10+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/07/mi-48396.jpeg https://hospitalpharmacyeurope.com/clinical-zones/rheumatology/tildrakizumab-shows-promising-efficacy-and-safety-in-psoriatic-arthritis/ 2024-08-16T16:01:07+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/07/mi-48394.jpeg https://hospitalpharmacyeurope.com/clinical-zones/haematology/pixuvri-approved-for-use-in-europe/ 2024-08-16T16:02:04+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/07/mi-48393.jpeg https://hospitalpharmacyeurope.com/news/medicines-project-delivers-11-million-savings/ 2024-08-16T16:02:57+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/07/mi-48392.jpeg https://hospitalpharmacyeurope.com/clinical-zones/oncology/pharmacies-make-a-lifestyle-impact-for-patients-with-prostate-cancer/ 2024-08-16T16:03:16+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/07/mi-48388.jpeg https://hospitalpharmacyeurope.com/clinical-zones/oncology/awareness-campaign-on-occupational-bladder-cancer-to-be-launched/ 2024-08-16T16:04:01+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/07/mi-48389.jpeg https://hospitalpharmacyeurope.com/clinical-zones/oncology/protons-to-play-a-vital-role-in-the-battle-against-prostate-cancer/ 2024-08-16T16:04:16+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/07/mi-48387.jpeg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/phase-iiia-clinical-trial-data-presented-for-oral-semaglutide/ 2024-08-16T16:04:29+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/07/mi-48386.jpeg https://hospitalpharmacyeurope.com/clinical-zones/neurology/opioid-analgesics-increase-the-risk-of-pneumonia-among-persons-with-alzheimers-disease/ 2024-08-16T16:05:03+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/07/mi-48385.jpeg https://hospitalpharmacyeurope.com/clinical-zones/mental-health/zebinix-effective-as-adjunctive-therapy-in-epilepsy-patients-with-psychiatric-comorbidities/ 2024-08-16T16:05:59+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/07/mi-48384.jpeg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/omalizumab-significantly-reduced-nasal-polyps-and-congestion-in-chronic-rhinosinusitis/ 2024-08-16T16:06:25+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/07/mi-48383.jpeg https://hospitalpharmacyeurope.com/clinical-zones/oncology/pharmacists-are-vital-in-improving-pancreatic-cancer-survival-rates/ 2024-08-16T16:06:56+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/07/mi-48381.jpeg https://hospitalpharmacyeurope.com/clinical-zones/haematology/long-term-data-from-pivotal-phase-iii-studies-of-ibrutinib-presented-at-asco-and-eha/ 2024-08-16T16:07:31+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/07/mi-48382.jpeg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/75-of-asthma-sufferers-unable-to-work-to-their-full-potential/ 2024-08-16T16:12:21+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/07/Arrows.jpg https://hospitalpharmacyeurope.com/in-depth/views/expert-opinion-new-challenges-for-aseptic-drug-preparation/ 2024-08-16T16:12:38+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/07/Sessink2.jpg https://hospitalpharmacyeurope.com/wp-content/uploads/2019/07/Sessink-e1564493906587.jpg https://hospitalpharmacyeurope.com/news/high-levels-of-oestrogen-in-the-womb-linked-to-autism/ 2024-08-16T16:14:15+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/07/Oestrogen-GettyImages-1082276192.jpg https://hospitalpharmacyeurope.com/clinical-zones/antibiotics-can-inhibit-skin-lymphoma/ 2024-08-16T16:15:24+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/07/GettyImages-627038500.jpg https://hospitalpharmacyeurope.com/news/positive-opinion-for-cannabidiol-oral-solution-in-two-rare-childhood-onset-epilepsies/ 2024-08-16T16:16:01+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/07/GettyImages-1132110636-1.jpg https://hospitalpharmacyeurope.com/clinical-zones/gastroenterology/stelara-receives-positive-opinion-for-moderately-to-severely-active-ulcerative-colitis/ 2024-08-16T16:16:54+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/07/GettyImages-934521196.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/lonsurf-receives-positive-chmp-opinion/ 2024-08-16T16:17:56+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/07/GettyImages-897238610.jpg https://hospitalpharmacyeurope.com/reviews-research/an-introduction-to-pharmacogenomics/ 2024-08-16T16:19:06+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/07/DNA-graphic_GettyImages_1096919364_965x500px.jpg https://hospitalpharmacyeurope.com/reviews-research/copd-overview-of-updated-nice-guidance/ 2024-08-16T16:19:27+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/07/COPD_GettyImages_831149192_965x500px.jpg https://hospitalpharmacyeurope.com/reviews-research/the-future-of-hospital-pharmacy-regarding-robot-technology/ 2024-08-16T16:19:47+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/07/kraemer_conference_pic_965x500px.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/finger-prick-blood-test-could-safely-reduce-antibiotic-use-in-patients-with-copd/ 2024-08-16T16:20:12+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/07/elderly-patient_GettyImages_598165332_965x500px.jpg https://hospitalpharmacyeurope.com/news/bee-sting-vaccine-trial-holds-promise-against-allergic-reactions/ 2024-08-16T16:20:34+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/07/wasp_GettyImages_117307019_965x500px.jpg https://hospitalpharmacyeurope.com/news/low-doses-of-radiation-promote-cancer-capable-cells/ 2024-08-16T16:21:14+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/07/GettyImages-1071422636.jpg https://hospitalpharmacyeurope.com/reviews-research/sponsored-meeting-the-needs-of-parenteral-nutrition-patients/ 2024-08-16T16:21:43+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/07/hospital_bed_GettyImages_619266552_965x500px.jpg https://hospitalpharmacyeurope.com/wp-content/uploads/2019/07/Joeri_de_Cloet_300x300px.jpg https://hospitalpharmacyeurope.com/wp-content/uploads/2019/07/Irene_Kra%CC%88mer_300x300px_v2.jpg https://hospitalpharmacyeurope.com/wp-content/uploads/2019/07/Magdalena_Pietka_300x300px.jpg https://hospitalpharmacyeurope.com/wp-content/uploads/2019/07/Mariola_Sirvent_300x300px.jpg https://hospitalpharmacyeurope.com/reviews-research/sponsored-iv-ibuprofen-a-new-option-in-multimodal-analgesia/ 2024-08-16T16:22:11+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/07/recovering_from_surgery_GettyImages_840514774_965x500px.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/ivacaftor-may-reduce-common-infections-in-patients-with-cf/ 2024-08-16T16:22:34+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/07/GettyImages-1028376050.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/ribociclib-receives-nice-recommendation/ 2024-08-16T16:23:49+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/07/GettyImages-908091666.jpg https://hospitalpharmacyeurope.com/clinical-zones/haematology/interim-data-evaluating-elocta-for-immune-tolerance-induction-shared-at-isth-2019/ 2024-08-16T16:25:35+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/07/Interim-data-evaluating-Elocta-for-immune-tolerance-induction-shared-at-ISTH-2019.jpg https://hospitalpharmacyeurope.com/clinical-zones/eu-marketing-authorisation-for-dolutegravir-lamivudine/ 2024-08-16T16:28:48+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/07/EU-marketing-authorisation-for-dolutegravir-lamivudine.jpg https://hospitalpharmacyeurope.com/news/targeted-therapy-combination-improves-survival-in-patients-with-advanced-bowel-cancer/ 2024-08-16T16:29:22+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/07/mi-48408.jpeg https://hospitalpharmacyeurope.com/clinical-zones/gastroenterology/trial-demonstrates-efficacy-of-a-more-flexible-dose-of-regorafenib-to-relieve-side-effects-in-colon-cancer/ 2024-08-16T16:29:41+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/07/mi-48409.jpeg https://hospitalpharmacyeurope.com/news/scottish-medicines-consortium-recommends-daratumumab/ 2024-08-16T16:30:31+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/07/mi-48410.jpeg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/blood-pressure-drugs-may-be-linked-with-increased-risk-of-bowel-condition/ 2024-08-16T16:31:19+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/07/mi-48405.jpeg https://hospitalpharmacyeurope.com/clinical-zones/paediatrics/back-to-school-asthma-linked-to-tripling-in-rate-of-health-service-appointments/ 2024-08-16T16:31:33+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/07/mi-48406.jpeg https://hospitalpharmacyeurope.com/clinical-zones/neurology/study-suggests-ms-patients-are-at-a-greater-risk-of-cancer/ 2024-08-16T16:31:56+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/07/mi-48404.jpeg https://hospitalpharmacyeurope.com/clinical-zones/oncology/new-genetic-test-helps-predict-side-effects-of-chemotherapy/ 2024-08-16T16:32:59+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/07/mi-48403.jpeg https://hospitalpharmacyeurope.com/clinical-zones/oncology/antioxidants-implicated-in-new-understanding-of-how-lung-cancer-spreads/ 2024-08-16T16:33:24+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/07/mi-48402.jpeg https://hospitalpharmacyeurope.com/news/one-in-five-haematological-cancer-patients-suffer-blood-clots-or-bleeding/ 2024-08-16T16:34:14+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/07/mi-48401.jpeg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/patients-aged-18-29-receive-worst-asthma-care-in-uk-charity-reveals/ 2024-08-19T10:54:21+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/02/Respiratory-1.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/nice-recommends-verzenios-with-an-aromatase-inhibitor-ai-to-treat-metastatic-breast-cancer/ 2024-08-19T11:05:20+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2016/06/Oncology-breast.jpg https://hospitalpharmacyeurope.com/news/medicines-will-be-prioritised-over-vital-food-in-no-deal-brexit-says-uks-health-secretary/ 2024-08-19T11:10:26+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/07/mi-48283.jpeg https://hospitalpharmacyeurope.com/news/new-treatment-for-prostate-cancer-receives-european-licence/ 2024-08-19T11:12:48+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/07/mi-48277.jpeg https://hospitalpharmacyeurope.com/news/keele-university-awarded-over-2m-to-investigate-opioid-overprescribing/ 2024-08-19T11:15:59+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2002/12/Pain-management-2.jpg https://hospitalpharmacyeurope.com/news/three-things-uk-pharmacists-need-to-know-in-case-of-a-no-deal-brexit/ 2024-08-19T11:18:34+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2002/09/HPE-european-community.jpg https://hospitalpharmacyeurope.com/reviews-research/neonatal-parenteral-nutrition-and-the-importance-of-the-multidisciplinary-team-in-delivery/ 2024-08-21T13:58:47+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/08/Neonatal-parenteral-nutrition-and-the-importance-of-the-multidisciplinary-team-in-delivery.jpg https://hospitalpharmacyeurope.com/clinical-zones/neurology/early-alzheimers-decline-in-cognition-slowed-by-lecanemab/ 2024-08-28T09:46:55+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/11/Early-Alzheimers-decline-in-cognition-slowed-by-lecanemab.gif https://hospitalpharmacyeurope.com/clinical-zones/neurology/lecanemab-shows-promise-in-early-alzheimers-disease/ 2024-08-28T09:52:21+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/09/Lecanemab-shows-promise-in-early-Alzheimers-disease.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/single-dose-psilocybin-therapy-improves-major-depression-symptoms-in-cancer-patients/ 2024-08-30T14:50:44+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/04/Single-dose-psilocybin-therapy-improves-major-depression-symptoms-in-cancer-patients.jpg https://hospitalpharmacyeurope.com/clinical-zones/mental-health/psilocybin-associated-therapy-effective-for-treatment-resistant-major-depression/ 2024-08-30T14:57:04+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/11/Psilocybin-associated-therapy-effective-for-treatment-resistant-major-depression.gif https://hospitalpharmacyeurope.com/clinical-zones/mental-health/psilocybin-assisted-therapy-reduces-heavy-drinking-days-in-alcohol-use-disorder/ 2024-08-30T15:03:24+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/08/Psilocybin-assisted-therapy-reduces-heavy-drinking-days-in-alcohol-use-disorder.jpg https://hospitalpharmacyeurope.com/clinical-zones/medicines-safety/advice-on-dispensing-valproate-to-men-shared-by-gphc-following-drug-safety-update/ 2024-09-11T09:33:48+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2024/09/Advice_on_dispensing_valproate_to_men_shared_by_GPhC_following_Drug_Safety_Update.jpg https://hospitalpharmacyeurope.com/news/rps-announces-plans-to-pursue-royal-college-and-charitable-status/ 2024-09-16T13:14:32+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2024/09/RPS_announces_plans_to_pursue_Royal_College_and_charitable_status.jpg https://hospitalpharmacyeurope.com/pharmacy-practice/critical-care-and-mental-health-advanced-pharmacist-curricula-launched-by-rps/ 2024-09-26T10:46:35+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2024/09/Critical_care_and_mental_health_advanced_pharmacist_curricula_launched_by_RPS.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/neoadjuvant-chemotherapy-for-colon-cancer-improves-2-year-survival/ 2024-09-27T15:55:50+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/02/Neoadjuvant-chemotherapy-for-colon-cancer-improves-2-year-survival.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/implementing-shared-care-agreements-for-amiodarone-therapy-a-pharmacy-case-study/ 2024-10-10T07:58:00+00:00 https://s3-eu-west-2.amazonaws.com/images.hospitalpharmacyeurope.com/wp-media-folder-hospital-pharmacy-europe/wp-content/uploads/2024/09/Implementing_shared_care_agreements_for_amiodarone_therapy_a_pharmacy_case_study.jpg https://s3-eu-west-2.amazonaws.com/images.hospitalpharmacyeurope.com/wp-media-folder-hospital-pharmacy-europe/wp-content/uploads/2024/09/Table_1_Indications_for_amiodarone.jpg https://s3-eu-west-2.amazonaws.com/images.hospitalpharmacyeurope.com/wp-media-folder-hospital-pharmacy-europe/wp-content/uploads/2024/09/Table_2_Summary_of_common_amiodarone_adverse_effects.jpg https://hospitalpharmacyeurope.com/pharmacy-practice/fip-highlights-hospital-pharmacists-unique-role-to-support-medicines-access-via-rational-drug-use/ 2024-10-03T14:47:34+00:00 https://s3-eu-west-2.amazonaws.com/images.hospitalpharmacyeurope.com/wp-media-folder-hospital-pharmacy-europe/wp-content/uploads/2024/10/FIP_highlights_hospital_pharmacists_unique_role_to_support_medicines_access_via_rational_drug_use.jpg https://hospitalpharmacyeurope.com/clinical-zones/oral-vitamin-a-could-become-an-alternative-to-isotretinoin-for-acne/ 2024-10-07T15:02:30+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/07/Oral-vitamin-A-could-become-an-alternative-to-isotretinoin-for-acne.jpg https://hospitalpharmacyeurope.com/clinical-zones/emergency-and-critical-care/research-digest-the-advantages-of-clinical-pharmacists-in-the-icu/ 2024-10-08T07:51:00+00:00 https://s3-eu-west-2.amazonaws.com/images.hospitalpharmacyeurope.com/wp-media-folder-hospital-pharmacy-europe/wp-content/uploads/2024/10/Research_digest_The_advantages_of_clinical_pharmacists_in_the_ICU.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/research-digest-regulation-for-small-scale-preparation-of-unlicensed-radiopharmaceuticals/ 2024-10-16T07:42:00+00:00 https://s3-eu-west-2.amazonaws.com/images.hospitalpharmacyeurope.com/wp-media-folder-hospital-pharmacy-europe/wp-content/uploads/2024/10/Research_digest_regulation_for_small-scale_preparation_of_unlicensed_radiopharmaceuticals.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/research-digest-chemical-contamination-of-cancer-drugs-in-robotic-compounding/ 2024-10-29T08:36:00+00:00 https://s3-eu-west-2.amazonaws.com/images.hospitalpharmacyeurope.com/wp-media-folder-hospital-pharmacy-europe/wp-content/uploads/2024/10/Research_digest_Chemical_contamination_of_cancer_drugs_in_robotic_compounding.jpg https://hospitalpharmacyeurope.com/clinical-zones/paediatrics/targeted-treatments-for-childhood-febrile-illnesses-possible-with-new-immune-cell-insights/ 2024-10-25T07:50:00+00:00 https://s3-eu-west-2.amazonaws.com/images.hospitalpharmacyeurope.com/wp-media-folder-hospital-pharmacy-europe/wp-content/uploads/2024/10/Targeted_treatments_for_childhood_febrile_illnesses_possible_with_new_immune_cell_insights.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/research-digest-the-impact-of-drone-transportation-on-monoclonal-antibody-stability/ 2024-11-06T16:34:27+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2024/08/Research_digest_The_impact_of_drone_transportation_on_monoclonal_antibody_stability.jpg https://hospitalpharmacyeurope.com/wp-content/uploads/2024/08/Table_1_Summary_of_the_main_results_of_infusion_bag_analysis_HPE.jpg https://hospitalpharmacyeurope.com/news/do-you-have-an-innovative-hospital-pharmacy-project-to-showcase/ 2024-11-07T17:08:00+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2024/05/Do_you_have_an_innovative_hospital_pharmacy_project_to_showcase.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/using-mrna-to-fight-cancer-a-promising-vaccine-strategy/ 2024-11-25T08:43:00+00:00 https://s3-eu-west-2.amazonaws.com/images.hospitalpharmacyeurope.com/wp-media-folder-hospital-pharmacy-europe/wp-content/uploads/2024/11/Using_mRNA_to_fight_cancer_a_promising_vaccine_strategy.jpg https://hospitalpharmacyeurope.com/pharmacy-practice/five-innovations-shaping-the-future-of-pharmacy-2024-highlights/ 2024-12-05T09:03:00+00:00 https://s3-eu-west-2.amazonaws.com/images.hospitalpharmacyeurope.com/wp-media-folder-hospital-pharmacy-europe/wp-content/uploads/2024/11/Five_innovations_shaping_the_future_of_pharmacy_2024_highlights.jpg https://hospitalpharmacyeurope.com/clinical-zones/gastroenterology/supporting-gut-microbiome-equilibrium-via-faecal-microbiota-transplantation-fmt/ 2024-12-12T08:25:00+00:00 https://s3-eu-west-2.amazonaws.com/images.hospitalpharmacyeurope.com/wp-media-folder-hospital-pharmacy-europe/wp-content/uploads/2024/12/Supporting_gut_microbiome_equilibrium_via_faecal_microbiota_transplantation.jpg https://hospitalpharmacyeurope.com/clinical-zones/medicines-safety/research-digest-visual-inspection-methods-for-parenteral-products-in-hospital-pharmacy/ 2024-12-11T14:09:37+00:00 https://s3-eu-west-2.amazonaws.com/images.hospitalpharmacyeurope.com/wp-media-folder-hospital-pharmacy-europe/wp-content/uploads/2024/12/Research_digest_Visual_inspection_methods_for_parenteral_products_in_hospital_pharmacy.jpg https://hospitalpharmacyeurope.com/clinical-zones/emergency-and-critical-care/pharmacy-practice-in-emergency-care-patient-safeguarding/ 2024-12-12T10:21:32+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2024/07/Pharmacy_practice_in_emergency_care_patient_safeguarding.jpg https://hospitalpharmacyeurope.com/clinical-zones/mental-health/reflections-on-the-psychotropic-medication-in-children-and-young-peoples-mental-health-in-patient-services-improvement-programme/ 2024-12-12T10:23:47+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2024/04/Reflections_on_the_Psychotropic_Medication_in_Children_and_Young_Peoples_Mental_Health.jpg https://hospitalpharmacyeurope.com/clinical-zones/medicines-safety/hospital-pharmacist-led-re-evaluation-of-medication-errors-a-pilot-study/ 2024-12-12T10:25:03+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2024/08/Hospital_pharmacist-led_re-evaluation_of_medication_errors_a_pilot_study.jpg https://hospitalpharmacyeurope.com/wp-content/uploads/2024/08/Figure_1_Structured_medication_process_with_eight_main_categories.jpg https://hospitalpharmacyeurope.com/wp-content/uploads/2024/08/Figure_2_Flow_diagram_showing_the_selection_process_for_medication_errors_2.jpg https://hospitalpharmacyeurope.com/wp-content/uploads/2024/08/Table_1_Medication_error_rate_by_category.jpg https://hospitalpharmacyeurope.com/pharmacy-practice/health-technology/top-tips-for-effective-digital-transformation-and-closed-loop-medicines-management-clmm/ 2024-12-17T11:54:39+00:00 https://s3-eu-west-2.amazonaws.com/images.hospitalpharmacyeurope.com/wp-media-folder-hospital-pharmacy-europe/wp-content/uploads/2024/12/Top_tips_for_effective_digital_transformation_and_closed_loop_medicines_management.jpg https://hospitalpharmacyeurope.com/pharmacy-practice/research-digest-developing-targeted-medication-adherence-interventions-to-address-challenges-across-europe/ 2025-01-06T08:37:00+00:00 https://s3-eu-west-2.amazonaws.com/images.hospitalpharmacyeurope.com/wp-media-folder-hospital-pharmacy-europe/wp-content/uploads/2025/01/Research_digest_Developing_targeted_medication_adherence_interventions_to_address_challenges_across_Europe.gif https://hospitalpharmacyeurope.com/clinical-zones/medicines-safety/danish-pharmacists-develop-quick-guide-for-assessing-common-renal-risk-medications/ 2025-01-09T15:00:20+00:00 https://s3-eu-west-2.amazonaws.com/images.hospitalpharmacyeurope.com/wp-media-folder-hospital-pharmacy-europe/wp-content/uploads/2024/12/Danish_pharmacists_develop_quick_guide_for_assessing_common_renal_risk_medications.jpg https://hospitalpharmacyeurope.com/clinical-zones/paediatrics/paediatric-oral-compounding-expert-insights-from-a-global-study/ 2025-01-16T14:36:59+00:00 https://s3-eu-west-2.amazonaws.com/images.hospitalpharmacyeurope.com/wp-media-folder-hospital-pharmacy-europe/wp-content/uploads/2025/01/Paediatric_oral_compounding_expert_insights_from_a_global_study.jpg https://hospitalpharmacyeurope.com/news/updated-nice-me-cfs-guidance-designed-to-improve-awareness-and-understanding-of-condition/ 2025-01-17T16:15:14+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/11/GettyImages-1282490768.gif-mecfs.gif https://hospitalpharmacyeurope.com/clinical-zones/study-shows-higher-omega-3-intake-appears-to-reduce-severity-of-migraine/ 2025-01-17T16:15:16+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/07/HPE-GettyImages-1059259884.jpg https://hospitalpharmacyeurope.com/clinical-zones/study-suggests-limited-long-term-benefit-of-sleep-medication/ 2025-01-17T16:15:17+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/05/HPE-GettyImages-861276088.jpg https://hospitalpharmacyeurope.com/clinical-zones/mental-health/bringing-a-new-generation-of-drugs-to-patients/ 2025-01-17T16:15:18+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/CNS-1.jpg https://hospitalpharmacyeurope.com/news/nice-approves-avonex-as-treatment-option-for-people-with-ms/ 2025-01-17T16:15:19+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2003/01/HPE-miltiple-sclerosis.jpg https://hospitalpharmacyeurope.com/clinical-zones/neurology/ocrelizumab-receives-positive-chmp-opinion-for-use-in-two-forms-of-multiple-sclerosis/ 2025-01-17T16:15:19+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2018/01/Neurology-4.jpg https://hospitalpharmacyeurope.com/clinical-zones/neurology/ocrelizumab-gains-positive-chmp-opinion-for-relapsing-forms-of-multiple-sclerosis/ 2025-01-17T16:15:21+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2018/01/Neurology-4.jpg https://hospitalpharmacyeurope.com/clinical-zones/neurology/regulatory-approval-in-europe-granted-for-glatiramer-acetate-40mg-ml/ 2025-01-17T16:15:22+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/11/CNS-1.jpg https://hospitalpharmacyeurope.com/clinical-zones/neurology/nhs-england-enters-into-commercial-agreement-that-allows-ms-patients-immediate-access-to-therapy/ 2025-01-17T16:15:22+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/11/CNS-1.jpg https://hospitalpharmacyeurope.com/news/first-darunavir-based-single-tablet-regimen-for-the-treatment-of-hiv-1-recommended-for-approval/ 2025-01-17T16:15:23+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/07/HPE-HIV.jpg https://hospitalpharmacyeurope.com/clinical-zones/neurology/ms-patients-face-delays-in-accessing-treatments-that-could-help-slow-down-disability-progression/ 2025-01-17T16:15:24+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/11/CNS-1.jpg https://hospitalpharmacyeurope.com/clinical-zones/neurology/nusinersen-approved-in-the-eu-as-first-treatment-for-spinal-muscular-atrophy/ 2025-01-17T16:15:25+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/11/CNS-1.jpg https://hospitalpharmacyeurope.com/clinical-zones/rheumatology/new-data-shows-sirukumab-improves-the-signs-and-symptoms-of-moderately-to-severely-active-rheumatoid-arthritis/ 2025-01-17T16:15:25+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/09/Rheumatology-3.jpg https://hospitalpharmacyeurope.com/news/launch-of-innovative-social-media-campaign-to-mark-world-ms-day/ 2025-01-17T16:15:26+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/11/CNS-1.jpg https://hospitalpharmacyeurope.com/clinical-zones/neurology/nusinersen-receives-positive-chmp-opinion-for-the-treatment-of-spinal-muscular-atrophy/ 2025-01-17T16:15:27+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/11/CNS-1.jpg https://hospitalpharmacyeurope.com/clinical-zones/neurology/nice-recommends-zinbryta-for-treatment-of-relapsing-remitting-multiple-sclerosis/ 2025-01-17T16:15:28+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/11/CNS-1.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/cystic-fibrosis-and-disease-modification/ 2025-01-17T16:15:29+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2016/11/Shaw-table-1.JPG http://preview.hospitalpharmacyeurope.com/wp-content/uploads/2016/11/Shaw-table-1.JPG http://preview.hospitalpharmacyeurope.com/wp-content/uploads/2016/11/Shaw-table-2.JPG https://hospitalpharmacyeurope.com/news/tecfidera-real-world-studies-affirm-sustained-efficacy-and-safety-profile/ 2025-01-17T16:15:30+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/11/CNS-1.jpg https://hospitalpharmacyeurope.com/news/pre-exposure-prophylaxis-for-hiv/ 2025-01-17T16:15:31+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2016/08/HPE-HIV.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/disease-modification-in-cystic-fibrosis/ 2025-01-17T16:15:31+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2016/05/SHAW-table-1.JPG http://preview.hospitalpharmacyeurope.com/wp-content/uploads/2016/05/SHAW-table-1.JPG http://preview.hospitalpharmacyeurope.com/wp-content/uploads/2016/05/SHAW-table-2.JPG https://hospitalpharmacyeurope.com/clinical-zones/neurology/daclizumab-demonstrates-significant-sustained-improvements-in-cognition-compared-to-interferon-beta-1a-im/ 2025-01-17T16:15:32+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/11/CNS-1.jpg https://hospitalpharmacyeurope.com/clinical-zones/neurology/tecfidera-data-highlights-benefit-of-early-treatment-in-relapsing-remitting-multiple-sclerosis/ 2025-01-17T16:15:33+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/11/CNS-1.jpg https://hospitalpharmacyeurope.com/news/role-of-the-clinical-pharmacist-in-the-management-of-cf/ 2025-01-17T16:15:34+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2018/01/CNS-1.jpg https://hospitalpharmacyeurope.com/clinical-zones/dermatology/merck-initiates-phase-iii-study-of-msb11022-in-chronic-plaque-psoriasis/ 2025-01-17T16:15:34+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/05/GettyImages-636149292.jpg https://hospitalpharmacyeurope.com/clinical-zones/neurology/new-study-provides-insights-into-potential-treatment-of-severe-pain-in-parkinsons-disease/ 2025-01-17T16:15:35+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/11/CNS-1.jpg https://hospitalpharmacyeurope.com/clinical-zones/neurology/latest-treatments-in-the-management-of-ms-multiple-sclerosis/ 2025-01-17T16:15:36+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/11/CNS-1.jpg https://hospitalpharmacyeurope.com/news/first-investigational-medicine-to-show-positive-study-results-in-both-primary-progressive-and-relapsing-ms/ 2025-01-17T16:15:37+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/11/CNS-1.jpg https://hospitalpharmacyeurope.com/news/antiretroviral-therapy-and-treatment-of-hiv/ 2025-01-17T16:15:38+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2016/09/HPE-HIV.jpg https://hospitalpharmacyeurope.com/clinical-zones/neurology/nhs-england-approves-routine-commissioning-for-parkinsons-treatment-duodopa/ 2025-01-17T16:15:39+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/11/CNS-1.jpg https://hospitalpharmacyeurope.com/clinical-zones/haematology/new-treatment-for-rare-forms-of-leukaemia-available-across-scotland/ 2025-01-17T16:15:39+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/06/haematology-2.jpg https://hospitalpharmacyeurope.com/clinical-zones/immunology/mundipharma-launches-remsima-a-new-generation-value-based-monoclonal-antibody/ 2025-01-17T16:15:40+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/03/infectious-disease-965x500.jpg https://hospitalpharmacyeurope.com/news/treeway-b-v-and-lacdr-collaborate-on-als-therapy-development/ 2025-01-17T16:15:41+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/11/CNS-1.jpg https://hospitalpharmacyeurope.com/clinical-zones/neurology/bayer-remains-committed-to-supporting-nhs-with-improved-access-to-sativex/ 2025-01-17T16:15:42+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2018/02/HPE-epilepsy.jpg https://hospitalpharmacyeurope.com/news/roche-initiates-phase-iii-trials-for-lampalizumab-first-potential-treatment-for-geographic-atrophy/ 2025-01-17T16:15:44+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/09/HPE-osteoporosis.jpg https://hospitalpharmacyeurope.com/news/ebola-victims-include-pharmacy-professionals/ 2025-01-17T16:15:45+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/03/infectious-disease-965x500.jpg https://hospitalpharmacyeurope.com/clinical-zones/neurology/sativex-recommended-by-the-awmsg/ 2025-01-17T16:15:45+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2016/02/HPE-epilepsy.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/acapella-choice-helps-cystic-fibrosis-patients/ 2025-01-17T16:15:46+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/11/CNS-1.jpg https://hospitalpharmacyeurope.com/news/first-treatment-approved-for-multicentric-castlemans-disease-in-europe/ 2025-01-17T16:15:47+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2014/06/HPE-HIV.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/management-of-cystic-fibrosis/ 2025-01-17T16:15:48+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/11/CNS-1.jpg https://hospitalpharmacyeurope.com/news/bexsero-to-protect-students-against-potentially-deadly-meningitis-b/ 2025-01-17T16:15:49+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/11/CNS-1.jpg https://hospitalpharmacyeurope.com/news/a-new-test-for-meningitis/ 2025-01-17T16:15:50+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/11/CNS-1.jpg https://hospitalpharmacyeurope.com/news/the-changing-fortunes-of-dimethyl-fumarate/ 2025-01-17T16:15:50+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/11/CNS-1.jpg https://hospitalpharmacyeurope.com/news/novartis-supplies-menb-vaccine-bexsero-to-protect-princeton-students/ 2025-01-17T16:15:51+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/11/CNS-1.jpg https://hospitalpharmacyeurope.com/news/generics-and-hiv-cost-versus-care/ 2025-01-17T16:15:52+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2014/06/HPE-HIV.jpg https://hospitalpharmacyeurope.com/news/tivicay-for-treatment-of-hiv-receives-positive-chmp-opinion/ 2025-01-17T16:15:53+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2014/06/HPE-HIV.jpg https://hospitalpharmacyeurope.com/news/novartis-gilenya-long-term-efficacy-on-reducing-brain-volume-loss-and-real-world-relapse-rates-in-ms/ 2025-01-17T16:15:54+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/11/CNS-1.jpg https://hospitalpharmacyeurope.com/news/teriflunomide-a-new-choice-in-the-oral-ms-drug-market/ 2025-01-17T16:15:54+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/11/CNS-1.jpg https://hospitalpharmacyeurope.com/news/lemtrada-approved-in-eu-for-ms/ 2025-01-17T16:15:55+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/11/CNS-1.jpg https://hospitalpharmacyeurope.com/clinical-zones/paediatrics/fda-expands-age-indication-for-menveo/ 2025-01-17T16:15:56+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2015/08/Paediatrics-5.jpg https://hospitalpharmacyeurope.com/news/jcvi-not-to-recommend-bexsero/ 2025-01-17T16:15:57+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/03/infectious-disease-965x500.jpg https://hospitalpharmacyeurope.com/news/hiv-mortality-rates-identical/ 2025-01-17T16:16:42+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2016/09/HPE-HIV.jpg https://hospitalpharmacyeurope.com/clinical-zones/neurology/new-data-shows-gilenya-benefited-multiple-sclerosis/ 2025-01-17T16:16:43+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2016/02/HPE-epilepsy.jpg https://hospitalpharmacyeurope.com/news/switching-to-novartis-drug-gilenya/ 2025-01-17T16:16:43+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/11/CNS-1.jpg https://hospitalpharmacyeurope.com/news/world-ms-day/ 2025-01-17T16:16:44+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2002/09/CNS-1.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/treatment-with-vx-661-and-ivacaftor-result-in-improvements-in-lung-function-in-cf/ 2025-01-17T16:16:45+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/11/CNS-1.jpg https://hospitalpharmacyeurope.com/news/gw-pharmaceuticals-announces-sativex-rescheduled-in-the-uk/ 2025-01-17T16:16:46+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/11/CNS-1.jpg https://hospitalpharmacyeurope.com/clinical-zones/neurology/unmet-medical-need-of-multiple-sclerosis/ 2025-01-17T16:16:47+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/11/CNS-1.jpg https://hospitalpharmacyeurope.com/news/novartis-confirms-growing-gilenya-clinical-experience/ 2025-01-17T16:16:47+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/11/CNS-1.jpg https://hospitalpharmacyeurope.com/clinical-zones/neurology/collaboration-agreement-in-cognitive-disorders/ 2025-01-17T16:16:48+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2018/01/Neurology-4.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/ivacaftor-a-quantum-leap-in-treating-cystic-fibrosis/ 2025-01-17T16:16:49+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/11/CNS-1.jpg https://hospitalpharmacyeurope.com/news/global-perspectives-and-compounding-problems/ 2025-01-17T16:16:50+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/11/healthcare-worker-safety-3.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/the-future-for-patients-with-cystic-fibrosis-and-g551d/ 2025-01-17T16:16:50+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/11/CNS-1.jpg https://hospitalpharmacyeurope.com/news/unitaid-financed-project-to-increase-access-to-new-hiv-monitoring-technology/ 2025-01-17T16:16:51+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2014/06/HPE-HIV.jpg https://hospitalpharmacyeurope.com/news/european-commission-approves-prezista/ 2025-01-17T16:16:52+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2002/09/HPE-european-community.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/the-worlds-premier-cardiovascular-congress-goes-to-amsterdam/ 2025-01-17T16:16:53+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2018/04/Cardiovascular_1.jpg https://hospitalpharmacyeurope.com/clinical-zones/paediatrics/atherosclerosis-found-in-hiv-children/ 2025-01-17T16:16:54+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2015/08/Paediatrics-5.jpg https://hospitalpharmacyeurope.com/news/fda-approval-of-rebif-rebidose/ 2025-01-17T16:16:54+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/11/CNS-1.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/pathophysiology-of-cystic-fibrosis-an-overview/ 2025-01-17T16:16:55+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/11/CNS-1.jpg https://hospitalpharmacyeurope.com/news/gilenya-shows-significant-early-effect-on-reducing-brain-volume-loss/ 2025-01-17T16:16:56+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2018/01/CNS-1.jpg https://hospitalpharmacyeurope.com/news/novartis-ms-portfolio-presence-at-28th-ectrims/ 2025-01-17T16:16:57+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/11/CNS-1.jpg https://hospitalpharmacyeurope.com/news/ampyra-two-year-safety-data/ 2025-01-17T16:16:57+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/11/CNS-1.jpg https://hospitalpharmacyeurope.com/news/peripheral-nerve-stimulation-study/ 2025-01-17T16:16:58+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/11/CNS-1.jpg https://hospitalpharmacyeurope.com/clinical-zones/mental-health/world-alzheimers-day-eahp-president-highlights-the-need-for-dementia-friendly-health-systems/ 2025-01-17T16:16:59+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2018/03/Neurology-6.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/ec-approves-kalydeco-for-cystic-fibrosis/ 2025-01-17T16:17:00+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/11/CNS-1.jpg https://hospitalpharmacyeurope.com/news/mri-findings-dispute-blood-flow-and-ms-correlation/ 2025-01-17T16:17:00+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2018/01/CNS-1.jpg https://hospitalpharmacyeurope.com/news/hrt-still-acceptable-for-menopausal-symptoms/ 2025-01-17T16:17:01+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2002/03/Anticoagulation-3.jpg https://hospitalpharmacyeurope.com/news/nevirapine-efficacious-in-african-women-with-hiv/ 2025-01-17T16:17:02+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2014/06/HPE-HIV.jpg https://hospitalpharmacyeurope.com/news/another-ms-pill-submitted-to-ema-for-approval/ 2025-01-17T16:17:03+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/11/CNS-1.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/ema-recommends-kalydeco-for-cystic-fibrosis/ 2025-01-17T16:17:04+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2002/09/CNS-1.jpg https://hospitalpharmacyeurope.com/clinical-zones/neurology/gilenya-safety-and-efficacy-consistent-for-4-5-years/ 2025-01-17T16:17:04+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/11/CNS-1.jpg https://hospitalpharmacyeurope.com/news/sorafenib-beats-temsirolimus-in-phase-3/ 2025-01-17T16:17:05+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/11/CNS-1.jpg https://hospitalpharmacyeurope.com/news/nice-turns-down-benlysta-on-grounds-of-cost/ 2025-01-17T16:17:08+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/11/CNS-1.jpg https://hospitalpharmacyeurope.com/news/chmp-confirms-gilenya-positive-benefit-risk-balance/ 2025-01-17T16:17:09+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/11/CNS-1.jpg https://hospitalpharmacyeurope.com/news/new-fingolimod-data-to-be-released-at-aan/ 2025-01-17T16:17:10+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/11/CNS-1.jpg https://hospitalpharmacyeurope.com/news/rebif-in-the-treatment-of-ms/ 2025-01-17T16:17:11+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/11/CNS-1.jpg https://hospitalpharmacyeurope.com/news/ms-pill-laquinimod-shows-efficacy-at-phase-3/ 2025-01-17T16:17:13+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/11/CNS-1.jpg https://hospitalpharmacyeurope.com/news/alemtuzumab-extension-confirms-safety-and-efficacy/ 2025-01-17T16:17:14+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/11/CNS-1.jpg https://hospitalpharmacyeurope.com/news/rebif-approved-for-single-ms-episode/ 2025-01-17T16:17:15+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/11/CNS-1.jpg https://hospitalpharmacyeurope.com/news/ema-releases-biosimilar-interferon-beta-guide/ 2025-01-17T16:17:16+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/11/CNS-1.jpg https://hospitalpharmacyeurope.com/news/ema-starts-review-of-killer-ms-drug-gilenya/ 2025-01-17T16:17:17+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/11/CNS-1.jpg https://hospitalpharmacyeurope.com/news/hiv-cure-discussed-at-international-workshop/ 2025-01-17T16:17:18+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2002/12/HPE-Antiretroviral.jpg https://hospitalpharmacyeurope.com/news/gilenya-positive-for-relapsing-remitting-ms/ 2025-01-17T16:17:18+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/11/CNS-1.jpg https://hospitalpharmacyeurope.com/news/first-generic-of-cholesterol-drug-lipitor-approved-in-us/ 2025-01-17T16:17:19+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2018/04/Cardiovascular_1.jpg https://hospitalpharmacyeurope.com/clinical-zones/neurology/interferon-b-first-line-therapy-in-multiple-sclerosis/ 2025-01-17T16:17:20+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2018/01/CNS-1.jpg https://hospitalpharmacyeurope.com/news/british-hiv-association-warns-of-epidemic/ 2025-01-17T16:17:21+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2002/12/HPE-Antiretroviral.jpg https://hospitalpharmacyeurope.com/news/ema-backs-new-rebif-for-relapsing-ms/ 2025-01-17T16:17:22+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/11/CNS-1.jpg https://hospitalpharmacyeurope.com/news/edurant-approved-for-hiv-1-treatment/ 2025-01-17T16:17:22+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2002/12/HPE-Antiretroviral.jpg https://hospitalpharmacyeurope.com/news/new-drug-target-can-stop-debilitating-ms/ 2025-01-17T16:17:23+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/11/CNS-1.jpg https://hospitalpharmacyeurope.com/news/hydrogen-peroxide-vapour-hailed-at-conference/ 2025-01-17T16:17:24+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/11/CNS-1.jpg https://hospitalpharmacyeurope.com/news/ectrims-ms-drug-on-show-at-amsterdam-congress/ 2025-01-17T16:17:25+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2002/03/CNS-1.jpg https://hospitalpharmacyeurope.com/news/innovative-therapies-receive-japanese-approval/ 2025-01-17T16:18:43+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/11/CNS-1.jpg https://hospitalpharmacyeurope.com/news/hiv-patients-living-15-years-longer-study-finds/ 2025-01-17T16:18:43+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/11/CNS-1.jpg https://hospitalpharmacyeurope.com/news/ema-recommends-edurant-for-hiv-1-approval/ 2025-01-17T16:18:44+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2002/09/CNS-1.jpg https://hospitalpharmacyeurope.com/news/viramune-approved-in-eu-for-hiv-1-treatment/ 2025-01-17T16:18:45+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/11/CNS-1.jpg https://hospitalpharmacyeurope.com/clinical-zones/neurology/merck-kgaa-acquires-multiple-sclerosis-drug/ 2025-01-17T16:18:46+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/11/CNS-1.jpg https://hospitalpharmacyeurope.com/clinical-zones/neurology/multiple-sclerosis-recent-treatment-advances/ 2025-01-17T16:18:47+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/11/CNS-1.jpg https://hospitalpharmacyeurope.com/news/fda-approve-drug-for-treatment-of-hiv/ 2025-01-17T16:18:48+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2002/12/HPE-Antiretroviral.jpg https://hospitalpharmacyeurope.com/news/antidepressant-may-cause-abnormal-heart-rhythms/ 2025-01-17T16:18:48+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2018/01/Neurology-4.jpg https://hospitalpharmacyeurope.com/news/nnrti-shows-efficacy-in-phase-3-hiv-trial/ 2025-01-17T16:18:49+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2014/06/HPE-HIV.jpg https://hospitalpharmacyeurope.com/news/application-for-hiv-drug-submitted-to-ema/ 2025-01-17T16:18:50+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/CNS-1.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/new-microarray-test-for-cystic-fibrosis-detection/ 2025-01-17T16:18:51+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2015/11/Respiratory-4.jpg https://hospitalpharmacyeurope.com/news/merck-applies-for-rebif-extension-in-europe/ 2025-01-17T16:18:52+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/CNS-1.jpg https://hospitalpharmacyeurope.com/clinical-zones/neurology/new-restless-legs-syndrome-treatment-analysed/ 2025-01-17T16:18:53+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2001/12/CNS-3.jpg https://hospitalpharmacyeurope.com/news/treatment-of-spasticity-due-to-ms-approved-in-germany/ 2025-01-17T16:18:54+00:00 https://hospitalpharmacyeurope.com/clinical-zones/neurology/study-examined-effects-of-neupro-in-parkinsons-disease/ 2025-01-17T16:18:54+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2001/12/CNS-3.jpg https://hospitalpharmacyeurope.com/news/researchers-make-aids-breakthrough/ 2025-01-17T16:18:55+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/CNS-1.jpg https://hospitalpharmacyeurope.com/news/first-ms-pill-gets-green-light/ 2025-01-17T16:18:56+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/CNS-1.jpg https://hospitalpharmacyeurope.com/news/antiretroviral-therapy-issues-new-drugs-and-challenges/ 2025-01-17T16:18:57+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/CNS-1.jpg https://hospitalpharmacyeurope.com/clinical-zones/neurology/cannabinoids-in-multiple-sclerosis-management/ 2025-01-17T16:18:58+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/CNS-1.jpg https://hospitalpharmacyeurope.com/news/eu-approves-first-oral-ms-treatment/ 2025-01-17T16:18:59+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/CNS-1.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/italy-teams-up-with-singapore-to-further-cancer-research/ 2025-01-17T16:18:59+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/06/Oncology-1.jpg https://hospitalpharmacyeurope.com/news/impressive-phase-iii-findings-for-cf-developmental-drug/ 2025-01-17T16:19:00+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/CNS-1.jpg https://hospitalpharmacyeurope.com/news/prezista-tablets-approved-for-select-adults-with-hiv/ 2025-01-17T16:19:01+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/CNS-1.jpg https://hospitalpharmacyeurope.com/news/sativex-improves-spasticity-symptoms-in-half-of-ms-patients/ 2025-01-17T16:19:02+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/CNS-1.jpg https://hospitalpharmacyeurope.com/news/ms-spasticity-treatment-granted-national-reimbursement-in-spain/ 2025-01-17T16:19:03+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/CNS-1.jpg https://hospitalpharmacyeurope.com/news/swissmedic-approves-ms-treatment/ 2025-01-17T16:19:04+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/CNS-1.jpg https://hospitalpharmacyeurope.com/clinical-zones/neurology/large-scale-parkinsons-trial/ 2025-01-17T16:19:05+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/CNS-1.jpg https://hospitalpharmacyeurope.com/news/novartis-ms-treatment/ 2025-01-17T16:19:05+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/CNS-1.jpg https://hospitalpharmacyeurope.com/news/study-success-for-type-1-gaucher-disease/ 2025-01-17T16:19:06+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/CNS-1.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/warning-over-hiv-drug-combination/ 2025-01-17T16:19:07+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/CNS-1.jpg https://hospitalpharmacyeurope.com/clinical-zones/neurology/multiple-sclerosis-drug-success/ 2025-01-17T16:19:08+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/CNS-1.jpg https://hospitalpharmacyeurope.com/news/lundbeck-and-genmab-enter-into-a-research-collaboration/ 2025-01-17T16:19:09+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/CNS-1.jpg https://hospitalpharmacyeurope.com/news/embryonic-stem-cell-trial-under-way/ 2025-01-17T16:19:10+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/CNS-1.jpg https://hospitalpharmacyeurope.com/clinical-zones/neurology/research-could-help-greater-insight-in-parkinsons-disease/ 2025-01-17T16:19:11+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/Neurology-4.jpg https://hospitalpharmacyeurope.com/news/clinical-trials-need-more-women/ 2025-01-17T16:19:12+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2014/06/HPE-HIV.jpg https://hospitalpharmacyeurope.com/news/call-for-vitamin-pills-to-fight-ms/ 2025-01-17T16:19:12+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/CNS-1.jpg https://hospitalpharmacyeurope.com/news/novartis-gains-fda-approval-for-gilenya/ 2025-01-17T16:19:13+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/CNS-1.jpg https://hospitalpharmacyeurope.com/news/nhs-expects-rise-in-hiv-patients/ 2025-01-17T16:19:14+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/CNS-1.jpg https://hospitalpharmacyeurope.com/news/four-in-one-hiv-drug-passes-tests/ 2025-01-17T16:19:15+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2014/06/HPE-HIV.jpg https://hospitalpharmacyeurope.com/news/novartis-announces-russian-regulatory-approval-for-gilenya/ 2025-01-17T16:19:16+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/CNS-1.jpg https://hospitalpharmacyeurope.com/news/ms-gel-approval-delayed-over-label/ 2025-01-17T16:19:16+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/CNS-1.jpg https://hospitalpharmacyeurope.com/news/tibotec-seeks-marketing-authorisation-for-hiv-drug/ 2025-01-17T16:19:17+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/CNS-1.jpg https://hospitalpharmacyeurope.com/news/hiv-drug-available-to-more-patients/ 2025-01-17T16:19:18+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/CNS-1.jpg https://hospitalpharmacyeurope.com/clinical-zones/neurology/the-treatment-of-multiple-sclerosis-update-on-oral-therapies/ 2025-01-17T16:19:19+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/Neurology-4.jpg https://hospitalpharmacyeurope.com/news/tmc278-pivotal-phase-3-clinical-trials-achieve-primary-objective/ 2025-01-17T16:19:20+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/CNS-1.jpg https://hospitalpharmacyeurope.com/news/plant-problems-hit-genzyme-output/ 2025-01-17T16:19:20+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/CNS-1.jpg https://hospitalpharmacyeurope.com/news/signs-of-success-for-immunoxel-drug/ 2025-01-17T16:19:21+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2014/06/HPE-HIV.jpg https://hospitalpharmacyeurope.com/news/trial-begins-for-ms-treatment-drug/ 2025-01-17T16:19:22+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/CNS-1.jpg https://hospitalpharmacyeurope.com/news/cannabis-based-ms-drug-launched/ 2025-01-17T16:19:23+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/CNS-1.jpg https://hospitalpharmacyeurope.com/clinical-zones/neurology/sativex-launched-in-uk-for-the-treatment-of-spasticity-due-to-multiple-sclerosis/ 2025-01-17T16:19:55+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/CNS-1.jpg https://hospitalpharmacyeurope.com/news/fda-backs-ms-pill-for-further-study/ 2025-01-17T16:19:56+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/CNS-1.jpg https://hospitalpharmacyeurope.com/news/fda-recommends-approval-of-novartis-investigational-treatment-fty720/ 2025-01-17T16:19:57+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/CNS-1.jpg https://hospitalpharmacyeurope.com/news/merck-resubmits-us-application-for-cladribine-tablets/ 2025-01-17T16:19:58+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/CNS-1.jpg https://hospitalpharmacyeurope.com/news/safety-concerns-over-new-ms-pill/ 2025-01-17T16:19:59+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/CNS-1.jpg https://hospitalpharmacyeurope.com/clinical-zones/neurology/the-treatment-for-multiple-sclerosis-emerging-oral-drugs/ 2025-01-17T16:20:00+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2016/06/Oncology-4.jpg https://hospitalpharmacyeurope.com/news/merck-seeking-approval-for-ms-pill/ 2025-01-17T16:20:01+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/CNS-1.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/report-of-the-15th-anniversary-congress-of-european-association-of-hospital-pharmacists/ 2025-01-17T16:20:02+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/08/Cardiovascular_1.jpg https://hospitalpharmacyeurope.com/news/results-from-betaferon-trial-published/ 2025-01-17T16:20:02+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/CNS-1.jpg https://hospitalpharmacyeurope.com/clinical-zones/mental-health/stelara-improves-symptoms-of-depression/ 2025-01-17T16:20:03+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2015/10/Mental-health-1.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/avandia-trial-risky-group-claims/ 2025-01-17T16:20:04+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/08/Cardiovascular_1.jpg https://hospitalpharmacyeurope.com/news/novartis-to-settle-tobramycin-case/ 2025-01-17T16:20:05+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/CNS-1.jpg https://hospitalpharmacyeurope.com/news/once-a-day-pill-cuts-ms-relapse/ 2025-01-17T16:20:06+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/CNS-1.jpg https://hospitalpharmacyeurope.com/news/hiv-drug-combination-shows-promise/ 2025-01-17T16:20:06+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/03/infectious-disease-965x500.jpg https://hospitalpharmacyeurope.com/news/novartis-investigational-ms-therapy-gilenia-shown-to-reduce-relapse-rates/ 2025-01-17T16:20:07+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/CNS-1.jpg https://hospitalpharmacyeurope.com/news/gilead-to-test-four-in-one-hiv-drug/ 2025-01-17T16:20:08+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2014/06/HPE-HIV.jpg https://hospitalpharmacyeurope.com/news/hiv-protein-method-find-important/ 2025-01-17T16:20:09+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2016/11/Infectious-disease-4.jpg https://hospitalpharmacyeurope.com/news/roche-expands-its-position-in-the-growing-insulin-delivery-systems-market/ 2025-01-17T16:20:09+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/Diabetes-2.jpg https://hospitalpharmacyeurope.com/clinical-zones/neurology/lithium-ineffective-as-als-drug/ 2025-01-17T16:20:10+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/CNS-1.jpg https://hospitalpharmacyeurope.com/news/bananas-hold-key-to-fighting-hiv/ 2025-01-17T16:20:11+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2014/06/HPE-HIV.jpg https://hospitalpharmacyeurope.com/news/new-ms-drug-given-priority-status/ 2025-01-17T16:20:12+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/CNS-1.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/glaxo-rejects-asthma-drug-claims/ 2025-01-17T16:20:13+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2014/06/HPE-asthma.jpg https://hospitalpharmacyeurope.com/news/technology-is-drug-firms-future/ 2025-01-17T16:20:13+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/11/HPE-mental-health-pharmacist.jpg https://hospitalpharmacyeurope.com/news/tablet-to-aid-ms-sufferers-approved/ 2025-01-17T16:20:14+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/CNS-1.jpg https://hospitalpharmacyeurope.com/news/scientists-shed-new-light-on-walking/ 2025-01-17T16:20:15+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/CNS-1.jpg https://hospitalpharmacyeurope.com/news/novartis-oral-ms-therapy-shows-reduced-risk-of-confirmed-disability-progression/ 2025-01-17T16:20:16+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/CNS-1.jpg https://hospitalpharmacyeurope.com/news/biogen-asks-for-ms-drug-approval/ 2025-01-17T16:20:17+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/CNS-1.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/cancer-drugs-could-help-fight-ms/ 2025-01-17T16:20:17+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/08/Oncology-1.jpg https://hospitalpharmacyeurope.com/news/hiv-cut-hope-with-new-molecule/ 2025-01-17T16:20:18+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2014/06/HPE-HIV.jpg https://hospitalpharmacyeurope.com/news/hiv-combination-therapy-offers-hope/ 2025-01-17T16:20:19+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/03/infectious-disease-965x500.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/drug-approved-for-cystic-fibrosis/ 2025-01-17T16:20:20+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/CNS-1.jpg https://hospitalpharmacyeurope.com/news/merck-kgaa-receives-refuse-to-file-letter-from-fda/ 2025-01-17T16:20:21+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/CNS-1.jpg https://hospitalpharmacyeurope.com/news/ms-drug-scheme-faces-criticism/ 2025-01-17T16:20:21+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/CNS-1.jpg https://hospitalpharmacyeurope.com/news/warning-over-new-hiv-drugs-advice/ 2025-01-17T16:20:22+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2014/06/HPE-HIV.jpg https://hospitalpharmacyeurope.com/news/medicines-agency-reaffirms-safety-of-h1n1-vaccines/ 2025-01-17T16:20:23+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/05/GettyImages-1126063131.jpg https://hospitalpharmacyeurope.com/news/lundbeck-starts-clinical-phase-iia-with-lu-aa24493-cepo/ 2025-01-17T16:20:24+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/CNS-1.jpg https://hospitalpharmacyeurope.com/news/hiv-resistance-prompts-vaccine-hope/ 2025-01-17T16:20:25+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2014/06/HPE-HIV.jpg https://hospitalpharmacyeurope.com/news/new-ms-drug-is-safe-and-effective/ 2025-01-17T16:20:26+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/CNS-1.jpg https://hospitalpharmacyeurope.com/news/novartis-ms-therapy-reduces-relapses-and-disability-progression/ 2025-01-17T16:20:27+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/CNS-1.jpg https://hospitalpharmacyeurope.com/news/new-data-presented-at-25th-ectrims-congress/ 2025-01-17T16:20:28+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/CNS-1.jpg https://hospitalpharmacyeurope.com/clinical-zones/neurology/results-show-mri-benefits-of-rebif/ 2025-01-17T16:20:29+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/CNS-1.jpg https://hospitalpharmacyeurope.com/news/prezista-darunavir-launched-in-the-uk/ 2025-01-17T16:20:30+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2014/06/HPE-HIV.jpg https://hospitalpharmacyeurope.com/news/warning-issued-over-hiv-drug-effects/ 2025-01-17T16:20:30+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2014/06/HPE-HIV.jpg https://hospitalpharmacyeurope.com/news/blood-pressure-drug-could-combat-ms/ 2025-01-17T16:20:31+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/CNS-1.jpg https://hospitalpharmacyeurope.com/news/us-fda-approves-extavia/ 2025-01-17T16:20:32+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/CNS-1.jpg https://hospitalpharmacyeurope.com/news/darunavir-is-not-inferior-to-lopinavir-and-ritonavir-treatment/ 2025-01-17T16:20:33+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2014/06/HPE-HIV.jpg https://hospitalpharmacyeurope.com/news/rna-hope-for-hiv-aids-treatment/ 2025-01-17T16:20:34+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2016/11/Infectious-disease-4.jpg https://hospitalpharmacyeurope.com/news/watchdog-expands-use-of-hiv-drug/ 2025-01-17T16:20:35+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/CNS-1.jpg https://hospitalpharmacyeurope.com/news/head-to-head-trial-proves-viramunes-effectiveness/ 2025-01-17T16:20:35+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/CNS-1.jpg https://hospitalpharmacyeurope.com/news/ucb-and-biogen-idec-discontinue-phase-ii-clinical-trial-of-cdp323/ 2025-01-17T16:21:06+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/CNS-1.jpg https://hospitalpharmacyeurope.com/news/merck-kgaa-launches-rebismart/ 2025-01-17T16:21:07+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/CNS-1.jpg https://hospitalpharmacyeurope.com/news/huntingtons-disease-breakthrough/ 2025-01-17T16:21:08+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/CNS-1.jpg https://hospitalpharmacyeurope.com/news/micafungin-in-the-treatment-of-fungal-infection/ 2025-01-17T16:21:09+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2014/06/HPE-HIV.jpg https://hospitalpharmacyeurope.com/news/glaxo-pfizer-hiv-drug-deal-probe/ 2025-01-17T16:21:09+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2014/06/HPE-HIV.jpg https://hospitalpharmacyeurope.com/clinical-zones/neurology/new-study-results-for-parkinsons-drug/ 2025-01-17T16:21:10+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/Neurology-4.jpg https://hospitalpharmacyeurope.com/news/pfizer-and-gsk-merge-hiv-divisions/ 2025-01-17T16:21:11+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2014/06/HPE-HIV.jpg https://hospitalpharmacyeurope.com/news/genzyme-and-bayer-healthcare-enter-new-strategic-agreement/ 2025-01-17T16:21:12+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/CNS-1.jpg https://hospitalpharmacyeurope.com/news/tibotec-pharmaceuticals-announce-phase-iii-trials-are-fully-recruited/ 2025-01-17T16:21:13+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/Safety-2-1.jpg https://hospitalpharmacyeurope.com/clinical-zones/neurology/merck-collaborate-to-develop-treatments-for-multiple-sclerosis/ 2025-01-17T16:21:14+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/CNS-1.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/study-confirms-herceptins-promise-of-extra-years-of-living-cancer-free/ 2025-01-17T16:21:15+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/08/Oncology-1.jpg https://hospitalpharmacyeurope.com/news/me-treatment-fight-to-be-resolved/ 2025-01-17T16:21:15+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/CNS-1.jpg https://hospitalpharmacyeurope.com/news/new-approach-to-eradicate-hiv/ 2025-01-17T16:21:16+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2014/06/HPE-HIV.jpg https://hospitalpharmacyeurope.com/news/prezista-approved-as-part-of-combination-therapy/ 2025-01-17T16:21:17+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/03/infectious-disease-965x500.jpg https://hospitalpharmacyeurope.com/news/positive-result-for-ms-drug-trial/ 2025-01-17T16:21:18+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/CNS-1.jpg https://hospitalpharmacyeurope.com/news/prezista-now-indicated-for-adults-living-with-hiv/ 2025-01-17T16:21:19+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2014/06/HPE-HIV.jpg https://hospitalpharmacyeurope.com/news/ms-drug-tysabri-showing-promise/ 2025-01-17T16:21:20+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2018/02/Neurology-1.jpg https://hospitalpharmacyeurope.com/news/tibotec-submits-application-to-us-fda-for-intelence/ 2025-01-17T16:21:21+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2014/06/HPE-HIV.jpg https://hospitalpharmacyeurope.com/news/merck-kgaa-announce-results-of-phase-iii-trial-of-ms-drug/ 2025-01-17T16:21:22+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/CNS-1.jpg https://hospitalpharmacyeurope.com/news/novartis-launches-extavia/ 2025-01-17T16:21:23+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/CNS-1.jpg https://hospitalpharmacyeurope.com/news/prezista-receives-expanded-marketing-authorisation/ 2025-01-17T16:21:24+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2014/06/HPE-HIV.jpg https://hospitalpharmacyeurope.com/news/novartis-ms-drug-shows-superior-efficacy/ 2025-01-17T16:21:24+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/CNS-1.jpg https://hospitalpharmacyeurope.com/news/protein-used-in-fight-against-aids/ 2025-01-17T16:21:25+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2014/06/HPE-HIV.jpg https://hospitalpharmacyeurope.com/news/top-line-results-for-fibromyalgia-treatment/ 2025-01-17T16:21:26+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/CNS-1.jpg https://hospitalpharmacyeurope.com/news/hiv-vaccine-trial-a-total-failure/ 2025-01-17T16:21:27+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2014/06/HPE-HIV.jpg https://hospitalpharmacyeurope.com/news/prezista-non-inferior-to-lopinavir-for-hiv/ 2025-01-17T16:21:28+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2014/06/HPE-HIV.jpg https://hospitalpharmacyeurope.com/news/ms-blood-test-breakthrough-hailed/ 2025-01-17T16:21:29+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/CNS-1.jpg https://hospitalpharmacyeurope.com/news/ms-drug-reverses-disability/ 2025-01-17T16:21:29+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/CNS-1.jpg https://hospitalpharmacyeurope.com/news/associated-predictors-of-medication-adherence-in-hiv-positive-adults/ 2025-01-17T16:21:30+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2014/06/HPE-HIV.jpg https://hospitalpharmacyeurope.com/news/etravirine-the-first-second-generation-non-nucleoside-reverse-transcriptase-inhibitor/ 2025-01-17T16:21:31+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2014/06/HPE-HIV.jpg https://hospitalpharmacyeurope.com/news/emea-authorisation-for-etravirine/ 2025-01-17T16:21:32+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2014/06/HPE-HIV.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/cystic-fibrosis-drug-breakthrough/ 2025-01-17T16:21:33+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/CNS-1.jpg https://hospitalpharmacyeurope.com/news/hiv-patients-resistant-to-drugs/ 2025-01-17T16:21:34+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2018/01/Infectious-disease-2.jpg https://hospitalpharmacyeurope.com/news/ms-drugs-trial-gets-green-light/ 2025-01-17T16:21:34+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/CNS-1.jpg https://hospitalpharmacyeurope.com/news/hiv-tb-therapies-clash/ 2025-01-17T16:21:36+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2018/01/Infectious-disease-2.jpg https://hospitalpharmacyeurope.com/clinical-zones/paediatrics/hiv-drug-not-best-for-babies/ 2025-01-17T16:21:37+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2015/08/Paediatrics-5.jpg https://hospitalpharmacyeurope.com/news/drugs-raise-hiv-life-expectancy/ 2025-01-17T16:21:38+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2014/06/HPE-HIV.jpg https://hospitalpharmacyeurope.com/news/hope-for-huntingtons-patients/ 2025-01-17T16:21:39+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/CNS-1.jpg https://hospitalpharmacyeurope.com/news/higher-dose-not-more-effective-for-ms-treatment/ 2025-01-17T16:21:40+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/CNS-1.jpg https://hospitalpharmacyeurope.com/news/deal-clears-way-for-ms-treatment/ 2025-01-17T16:21:41+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/CNS-1.jpg https://hospitalpharmacyeurope.com/news/axentis-acquires-rights-to-cf-screening-tool/ 2025-01-17T16:21:41+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/CNS-1.jpg https://hospitalpharmacyeurope.com/news/pill-a-new-option-for-ms-sufferers/ 2025-01-17T16:21:42+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/CNS-1.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/phase-iii-results-for-aztreonam-lysine-in-cystic-fibrosis/ 2025-01-17T16:21:43+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/CNS-1.jpg https://hospitalpharmacyeurope.com/news/protein-predictors-revealed-for-hiv-treatment/ 2025-01-17T16:21:44+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2014/06/HPE-HIV.jpg https://hospitalpharmacyeurope.com/news/etravirine-in-hiv-therapy-a-second-generation-non-nucleoside-reverse-transcriptase-inhibitor/ 2025-01-17T16:21:45+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2002/12/Infectious-disease-4.jpg https://hospitalpharmacyeurope.com/news/hiv-treatment-reaching-too-few/ 2025-01-17T16:21:45+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/05/Antimicrobial-resistance-1.jpg https://hospitalpharmacyeurope.com/news/ms-treatment-aids-mobility/ 2025-01-17T16:21:46+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/CNS-1.jpg https://hospitalpharmacyeurope.com/news/nine-national-approvals-for-loramyc/ 2025-01-17T16:21:47+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2002/12/Infectious-disease-4.jpg https://hospitalpharmacyeurope.com/news/eu-approval-for-ms-drug/ 2025-01-17T16:21:48+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/CNS-1.jpg https://hospitalpharmacyeurope.com/news/hiv-drugs-may-save-sight/ 2025-01-17T16:21:49+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2002/12/Infectious-disease-4.jpg https://hospitalpharmacyeurope.com/news/drugs-break-hiv-link-from-mother/ 2025-01-17T16:22:18+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2014/06/HPE-HIV.jpg https://hospitalpharmacyeurope.com/news/full-ec-approval-for-aptivus/ 2025-01-17T16:22:19+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2014/06/HPE-HIV.jpg https://hospitalpharmacyeurope.com/news/new-treatment-outfoxes-aids-virus/ 2025-01-17T16:22:20+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2014/06/HPE-HIV.jpg https://hospitalpharmacyeurope.com/clinical-zones/neurology/italians-show-cuts-in-ms-relapses/ 2025-01-17T16:22:20+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2018/03/Neurology-6.jpg https://hospitalpharmacyeurope.com/news/ms-relapse-rates-reduced/ 2025-01-17T16:22:21+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/CNS-1.jpg https://hospitalpharmacyeurope.com/news/superbug-detection-technique-found/ 2025-01-17T16:22:22+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/CNS-1.jpg https://hospitalpharmacyeurope.com/news/worlds-top-computer-battles-hiv/ 2025-01-17T16:22:23+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2014/06/HPE-HIV.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/maa-submitted-for-cystic-fibrosis-drug/ 2025-01-17T16:22:24+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/CNS-1.jpg https://hospitalpharmacyeurope.com/news/bioalliance-pharma-to-continue-with-advanced-compound-acquisition/ 2025-01-17T16:22:25+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2014/06/HPE-HIV.jpg https://hospitalpharmacyeurope.com/news/scientist-downbeat-on-aids-vaccine/ 2025-01-17T16:22:25+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2018/01/HPE-single-use-device.jpg https://hospitalpharmacyeurope.com/news/fda-approves-new-hiv-treatment/ 2025-01-17T16:22:26+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2016/11/Antimicrobial-resistance-3-1.jpg https://hospitalpharmacyeurope.com/news/firms-welcome-tysabri-results/ 2025-01-17T16:22:27+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/CNS-1.jpg https://hospitalpharmacyeurope.com/news/isentress-approved-to-treat-hiv/ 2025-01-17T16:22:28+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2014/06/HPE-HIV.jpg https://hospitalpharmacyeurope.com/news/emea-approves-single-dose-hiv-pill/ 2025-01-17T16:22:29+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2014/06/HPE-HIV.jpg https://hospitalpharmacyeurope.com/news/atripla-commercialised-in-europe-for-hiv-1-infection/ 2025-01-17T16:22:30+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2014/06/HPE-HIV.jpg https://hospitalpharmacyeurope.com/news/neupro-filed-with-fda-for-restless-legs-syndrome/ 2025-01-17T16:22:30+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/CNS-1.jpg https://hospitalpharmacyeurope.com/news/drug-companies-hailed-at-ceremony/ 2025-01-17T16:22:31+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2014/06/HPE-HIV.jpg https://hospitalpharmacyeurope.com/news/glatiramer-copaxone-protects-against-ms-progression/ 2025-01-17T16:22:32+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/CNS-1.jpg https://hospitalpharmacyeurope.com/news/ex-soviet-states-have-largest-number-of-new-hiv-rates/ 2025-01-17T16:22:33+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2014/06/HPE-HIV.jpg https://hospitalpharmacyeurope.com/news/merck-contacts-volunteers-after-hiv-study-stopped/ 2025-01-17T16:22:34+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2014/06/HPE-HIV.jpg https://hospitalpharmacyeurope.com/news/first-oral-class-hiv-medicine-in-decade-launched/ 2025-01-17T16:22:34+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2016/11/Infectious-disease-4.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/warning-over-herbal-impotency-pills/ 2025-01-17T16:22:35+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2014/06/HPE-viagra.jpg https://hospitalpharmacyeurope.com/news/fda-approves-lower-strength-kaletra/ 2025-01-17T16:22:36+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2016/11/Infectious-disease-4.jpg https://hospitalpharmacyeurope.com/news/tysabri-sales-boost-elans-results/ 2025-01-17T16:22:37+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/CNS-1.jpg https://hospitalpharmacyeurope.com/news/emea-lifts-suspension-on-viracept/ 2025-01-17T16:22:37+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2014/06/HPE-HIV.jpg https://hospitalpharmacyeurope.com/news/ms-drug-gains-scotland-approval/ 2025-01-17T16:22:38+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/CNS-1.jpg https://hospitalpharmacyeurope.com/news/nice-approves-drug-for-ms-patients/ 2025-01-17T16:22:39+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/CNS-1.jpg https://hospitalpharmacyeurope.com/news/promising-results-for-hiv-drug/ 2025-01-17T16:22:40+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2016/11/Infectious-disease-4.jpg https://hospitalpharmacyeurope.com/news/b-ms-drops-co-operative-hiv-venture/ 2025-01-17T16:22:41+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2014/06/HPE-HIV.jpg https://hospitalpharmacyeurope.com/news/uks-nice-backs-ms-drug/ 2025-01-17T16:22:42+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/CNS-1.jpg https://hospitalpharmacyeurope.com/news/study-finds-natalizumab-benefit-in-ms/ 2025-01-17T16:22:43+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/CNS-1.jpg https://hospitalpharmacyeurope.com/news/contamination-prompts-viracept-licence-suspension/ 2025-01-17T16:22:43+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2016/11/Infectious-disease-4.jpg https://hospitalpharmacyeurope.com/news/contamination-fear-prompts-viracept-recall/ 2025-01-17T16:22:44+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2014/06/HPE-HIV.jpg https://hospitalpharmacyeurope.com/news/conference-aims-to-boost-biotech/ 2025-01-17T16:22:45+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2002/06/Conference-report-2.jpg https://hospitalpharmacyeurope.com/clinical-zones/neurology/glaxosmithkline-strengthens-china-rd-presence/ 2025-01-17T16:22:46+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/Neurology-4.jpg https://hospitalpharmacyeurope.com/news/hiv-market-set-to-increase/ 2025-01-17T16:22:47+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2014/06/HPE-HIV.jpg https://hospitalpharmacyeurope.com/news/maraviroc-shows-potent-effect-in-treatment-experienced-hiv-patients/ 2025-01-17T16:22:48+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2014/06/HPE-HIV.jpg https://hospitalpharmacyeurope.com/news/polydex-pharma-hiv-drug-trials-halted/ 2025-01-17T16:22:49+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2014/06/HPE-HIV.jpg https://hospitalpharmacyeurope.com/news/pfizer-licenses-hiv-test-for-maraviroc-development/ 2025-01-17T16:22:49+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/03/infectious-disease-965x500.jpg https://hospitalpharmacyeurope.com/news/durable-medication-benefit-in-hiv-switch-patients/ 2025-01-17T16:22:50+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2014/06/HPE-HIV.jpg https://hospitalpharmacyeurope.com/news/once-daily-combination-therapies-in-hiv-patients/ 2025-01-17T16:22:51+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2016/09/HPE-HIV.jpg https://hospitalpharmacyeurope.com/news/once-daily-combination-therapies-in-hiv-patients-2/ 2025-01-17T16:22:52+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2014/06/HPE-HIV.jpg https://hospitalpharmacyeurope.com/news/immunotherapy-and-vaccines-for-hiv-1-treatment/ 2025-01-17T16:22:53+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2016/11/Infectious-disease-4.jpg https://hospitalpharmacyeurope.com/news/interventions-to-reduce-postnatal-hiv-transmission/ 2025-01-17T16:22:54+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2014/06/HPE-HIV.jpg https://hospitalpharmacyeurope.com/clinical-zones/neurology/advances-in-multiple-sclerosis-treatment/ 2025-01-17T16:22:54+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/CNS-1.jpg https://hospitalpharmacyeurope.com/news/tdm-and-adherence-in-hiv-patients/ 2025-01-17T16:22:55+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2004/03/HPE-HIV.jpg https://hospitalpharmacyeurope.com/news/recent-advances-in-the-treatment-of-hiv/ 2025-01-17T16:22:56+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/CNS-1.jpg https://hospitalpharmacyeurope.com/news/hiv-infection-in-older-patients-new-therapies/ 2025-01-17T16:22:57+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2004/03/HPE-HIV.jpg https://hospitalpharmacyeurope.com/news/nnrtis-for-the-treatment-of-hiv-1-infection/ 2025-01-17T16:22:58+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2004/03/HPE-HIV.jpg https://hospitalpharmacyeurope.com/news/once-a-day-combination-antiretroviral-therapy/ 2025-01-17T16:22:58+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2004/03/HPE-HIV.jpg https://hospitalpharmacyeurope.com/news/antiretroviral-therapy-with-nnrtis/ 2025-01-17T16:23:33+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2004/03/HPE-HIV.jpg https://hospitalpharmacyeurope.com/clinical-zones/neurology/immunomodulatory-drugs-for-multiple-sclerosis/ 2025-01-17T16:23:34+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/11/CNS-1.jpg https://hospitalpharmacyeurope.com/news/global-and-national-monitoring-systems/ 2025-01-17T16:23:35+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2016/11/Antimicrobial-resistance-3-1.jpg https://hospitalpharmacyeurope.com/news/using-it-for-medication-safety-systems-available/ 2025-01-17T16:23:36+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2016/01/Safety-1.jpg https://hospitalpharmacyeurope.com/clinical-zones/mental-health/managing-behavioural-problems-in-dementia/ 2025-01-17T16:23:37+00:00 https://hospitalpharmacyeurope.com/news/problems-associated-with-liver-transplantation/ 2025-01-17T16:23:37+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2003/11/Organ-transplant-2.jpg https://hospitalpharmacyeurope.com/clinical-zones/neurology/multiple-sclerosis-drugs-for-symptomatic-treatment/ 2025-01-17T16:23:38+00:00 https://hospitalpharmacyeurope.com/news/feedback-automation-systems-in-your-hospital/ 2025-01-17T16:23:39+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2003/01/HPE-automated-system.jpg https://hospitalpharmacyeurope.com/news/computer-based-formulary-management-systems/ 2025-01-17T16:23:40+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2002/12/HPE-laptop-1.jpg https://hospitalpharmacyeurope.com/clinical-zones/neurology/what-is-it-like-to-live-with-multiple-sclerosis/ 2025-01-17T16:23:40+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2003/01/HPE-miltiple-sclerosis.jpg https://hospitalpharmacyeurope.com/clinical-zones/neurology/a-comparison-of-multiple-sclerosis-dosing-schedules/ 2025-01-17T16:23:41+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2002/12/CNS-5.jpg https://hospitalpharmacyeurope.com/news/holiday-musings-global-healthcare-problems/ 2025-01-17T16:23:42+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2002/09/Drug-Shortage-1.jpg https://hospitalpharmacyeurope.com/news/safe-medication-systems-deja-vu-for-us-pharmacists/ 2025-01-17T16:23:43+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2002/09/healthcare-worker-safety-4.jpg https://hospitalpharmacyeurope.com/news/risk-sharing-scheme-for-the-provision-of-ms-drugs/ 2025-01-17T16:23:44+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2002/09/CNS-1.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/prevention-and-control-of-infection-in-cystic-fibrosis/ 2025-01-17T16:23:44+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2002/09/Infectious-disease-4.jpg https://hospitalpharmacyeurope.com/clinical-zones/neurology/whats-the-latest-in-ms-research/ 2025-01-17T16:23:45+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2002/03/CNS-1.jpg https://hospitalpharmacyeurope.com/clinical-zones/neurology/symptomatic-treatment-in-multiple-sclerosis/ 2025-01-17T16:23:46+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2001/12/CNS-3.jpg https://hospitalpharmacyeurope.com/clinical-zones/neurology/pharmacotherapeutic-choice-in-multiple-sclerosis/ 2025-01-17T16:23:47+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2001/09/Neurology-4.jpg https://hospitalpharmacyeurope.com/news/german-hospital-pharmacy-forges-ahead/ 2025-01-17T16:25:45+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/08/German-hospital-pharmacy-forges-ahead.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/sponsored-information-technology-and-robotics-for-chemotherapy/ 2025-01-17T16:25:46+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/05/robotics_Getty_861104740_965x500px.png https://hospitalpharmacyeurope.com/wp-content/uploads/2021/05/Laurence_Goldberg_150x150px.jpg https://hospitalpharmacyeurope.com/wp-content/uploads/2021/05/Estela_Moreno_Marti%CC%81nez_150x150px.jpg https://hospitalpharmacyeurope.com/wp-content/uploads/2021/05/Mattias_Paulsson_150x150px.jpg https://hospitalpharmacyeurope.com/wp-content/uploads/2021/05/Olga_Delgado_150x150px.jpg https://hospitalpharmacyeurope.com/news/ashp-unstoppable/ 2025-01-17T16:25:47+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/02/painted_hand_GettyImages_1271510376_965x500px.jpg https://hospitalpharmacyeurope.com/news/pharmacy-response-to-covid-19/ 2025-01-17T16:25:48+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/02/Covid19_GettyImages_1208691883_965x500px.jpg https://hospitalpharmacyeurope.com/news/sponsored-upholding-quality-patient-care-with-biosimilars/ 2025-01-17T16:25:49+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/08/conference_GettyImages_1023551840_965x500px.jpg https://hospitalpharmacyeurope.com/wp-content/uploads/2019/08/Amgen_Fig1.png https://hospitalpharmacyeurope.com/wp-content/uploads/2019/08/Amgen_Fig2.png https://hospitalpharmacyeurope.com/wp-content/uploads/2019/08/Amgen_Fig3.png https://hospitalpharmacyeurope.com/wp-content/uploads/2019/08/Amgen_Fig4.png https://hospitalpharmacyeurope.com/clinical-zones/changing-practice-to-improve-safety-2019/ 2025-01-17T16:25:50+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/07/conference_GettyImages_1023551840_965x500px.jpg https://hospitalpharmacyeurope.com/in-depth/views/evidence-based-practice-closing-the-loop/ 2025-01-17T16:25:50+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2019/07/exhibition_hall_GettyImages_933461772_965x500px.jpg https://hospitalpharmacyeurope.com/news/pn-a-new-focus-of-patient-centred-care/ 2025-01-17T16:25:53+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/12/Fresenius_Kabi_conference_report_400x162px.jpg https://hospitalpharmacyeurope.com/clinical-zones/medicines-safety/proactive-medication-error-avoidance/ 2025-01-17T16:25:54+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2016/11/Antimicrobial-resistance-3-1.jpg https://hospitalpharmacyeurope.com/news/gerpac-conference-report/ 2025-01-17T16:25:55+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2002/03/Safety-2.jpg https://hospitalpharmacyeurope.com/news/personalised-and-safe-therapy/ 2025-01-17T16:25:55+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2016/01/Safety-1.jpg https://hospitalpharmacyeurope.com/news/safe-handling-of-hazardous-drugs-2/ 2025-01-17T16:25:56+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/04/CSTD-safety.jpg https://hospitalpharmacyeurope.com/news/european-society-of-clinical-pharmacy-conference-report/ 2025-01-17T16:25:57+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2016/01/Nephrology-2.jpg https://hospitalpharmacyeurope.com/news/the-future-of-hospital-pharmacy-global-conference-report/ 2025-01-17T16:25:58+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/Safety-2-1.jpg https://hospitalpharmacyeurope.com/clinical-zones/medicines-safety/safe-handling-of-hazardous-drugs/ 2025-01-17T16:25:59+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2016/01/Safety-1.jpg https://hospitalpharmacyeurope.com/clinical-zones/haematology/new-therapies-a-challenge-for-21st-century-hospital-pharmacists/ 2025-01-17T16:25:59+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/haematology-2.jpg https://hospitalpharmacyeurope.com/clinical-zones/mental-health/psychiatry-update-escp-conference-report/ 2025-01-17T16:26:00+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2004/05/Psychiatry-4.jpg https://hospitalpharmacyeurope.com/news/clinical-pharmacy-and-the-ageing-patient/ 2025-01-17T16:26:01+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2003/09/Depression-7.jpg https://hospitalpharmacyeurope.com/news/welsh-government-to-invest-3-6m-in-multi-sector-pre-registration-training/ 2025-01-20T13:27:48+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/GettyImages-871424916.jpg https://hospitalpharmacyeurope.com/news/nhs-prescription-charge-to-rise-to-9-per-item-in-england/ 2025-01-20T13:27:50+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/GettyImages-871424916.jpg https://hospitalpharmacyeurope.com/clinical-zones/dermatology/nhs-on-track-to-make-300m-in-savings-after-adalimumab-deals/ 2025-01-20T13:27:51+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/GettyImages-871424916.jpg https://hospitalpharmacyeurope.com/news/cost-of-medicines-in-uk-more-than-doubles-in-less-than-a-decade-figures-reveal/ 2025-01-20T13:27:52+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/GettyImages-871424916.jpg https://hospitalpharmacyeurope.com/in-depth/views/gphc-proposes-raising-uk-registration-fees-for-first-time-since-2015/ 2025-01-20T13:27:53+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/GettyImages-871424916.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/pricing-revolution-needed-to-make-new-cancer-drugs-available-to-all/ 2025-01-20T13:27:54+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2018/05/Drug-Shortage-3.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/nice-draft-guidance-rejects-first-line-use-of-cabometyx-2/ 2025-01-20T13:27:54+00:00 https://hospitalpharmacyeurope.com/clinical-zones/oncology/dificlirtm-fidaxomicin-is-more-cost-effective-than-current-standard-of-care-in-cancer-patients/ 2025-01-20T13:27:55+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/06/Oncology-1.jpg https://hospitalpharmacyeurope.com/news/building-partnerships-in-care/ 2025-01-20T13:27:56+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2016/06/Patient-safety-2.jpg https://hospitalpharmacyeurope.com/clinical-zones/mental-health/paliperidone-palmitate-efficacy-and-cost-effectiveness/ 2025-01-20T13:27:57+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2016/02/HPE-epilepsy.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/cost-effective-prostate-cancer-treatment/ 2025-01-20T13:27:58+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2018/01/Oncology-1.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/bivalirudin-a-cost-effective-treatment-strategy-in-acs/ 2025-01-20T13:27:59+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2018/04/Cardiovascular_1.jpg https://hospitalpharmacyeurope.com/news/clinical-efficacy-and-cost-effectiveness-of-opat/ 2025-01-20T13:27:59+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2016/11/Antimicrobial-resistance-3-1.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/cost-effectiveness-and-affordability-in-cancer-care/ 2025-01-20T13:28:00+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/07/Oncology-1.jpg https://hospitalpharmacyeurope.com/news/pharmacists-play-key-role-in-saving-billions/ 2025-01-20T13:28:01+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/GettyImages-871424916.jpg https://hospitalpharmacyeurope.com/news/pricing-medicines/ 2025-01-20T13:28:02+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/GettyImages-871424916.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/cost-effectiveness-and-clinical-efficacy-of-pradaxa/ 2025-01-20T13:28:03+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2018/04/Cardiovascular_1.jpg https://hospitalpharmacyeurope.com/news/black-symbols-and-austerity/ 2025-01-20T13:28:03+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2016/01/Safety-1.jpg https://hospitalpharmacyeurope.com/news/benefits-and-cost-effectiveness-of-nivestim-for-febrile-neutropenia/ 2025-01-20T13:28:04+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/GettyImages-871424916.jpg https://hospitalpharmacyeurope.com/clinical-zones/rheumatology/cost-effectiveness-of-tnf-alpha-inhibitors-in-ra/ 2025-01-20T13:28:05+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2016/02/Rheumatology-2.jpg https://hospitalpharmacyeurope.com/clinical-zones/rheumatology/pharmacoeconomics-of-subcutaneous-methotrexate/ 2025-01-20T13:28:06+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2016/10/Rheumatology-2.jpg https://hospitalpharmacyeurope.com/news/drug-spend-in-europe-squeezed-most-by-austerity/ 2025-01-20T13:28:07+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/GettyImages-871424916.jpg https://hospitalpharmacyeurope.com/news/clinical-and-financial-risks-with-patient-access-schemes/ 2025-01-20T13:28:08+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/GettyImages-871424916.jpg https://hospitalpharmacyeurope.com/news/how-the-economic-crisis-affects-hospital-pharmacists/ 2025-01-20T13:28:09+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/GettyImages-871424916.jpg https://hospitalpharmacyeurope.com/news/polish-pharmaceutical-market-to-diminish-in-2012/ 2025-01-20T13:28:10+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2016/11/OTC-3.jpg https://hospitalpharmacyeurope.com/news/autumn-statement-has-limited-impact-for-bioscience/ 2025-01-20T13:28:10+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/GettyImages-871424916.jpg https://hospitalpharmacyeurope.com/news/ema-should-be-granted-budget-discharge-for-2009/ 2025-01-20T13:28:11+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/GettyImages-871424916.jpg https://hospitalpharmacyeurope.com/news/us-healthcare-one-of-least-cost-effective/ 2025-01-20T13:28:12+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/GettyImages-871424916.jpg https://hospitalpharmacyeurope.com/news/gps-facing-drugs-ban-over-cost/ 2025-01-20T13:28:13+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/GettyImages-871424916.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/ticagrelor-more-cost-effective-over-generic-clopidogrel/ 2025-01-20T13:28:13+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/08/Cardiovascular_1.jpg https://hospitalpharmacyeurope.com/news/automation-efficiencies-and-savings/ 2025-01-20T13:28:14+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/GettyImages-871424916.jpg https://hospitalpharmacyeurope.com/news/lundbeck-announces-financial-guidance/ 2025-01-20T13:28:15+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/GettyImages-871424916.jpg https://hospitalpharmacyeurope.com/news/snp-keeps-free-prescription-pledge/ 2025-01-20T13:28:16+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/GettyImages-871424916.jpg https://hospitalpharmacyeurope.com/news/government-in-30m-drug-payout/ 2025-01-20T13:28:17+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/GettyImages-871424916.jpg https://hospitalpharmacyeurope.com/news/superdrug-cuts-prescription-mark-up/ 2025-01-20T13:28:18+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/GettyImages-871424916.jpg https://hospitalpharmacyeurope.com/news/period-drug-could-save-thousands/ 2025-01-20T13:28:18+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/GettyImages-871424916.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/asthma-drug-not-value-for-money%c2%9d/ 2025-01-20T13:28:19+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2015/11/Respiratory-4.jpg https://hospitalpharmacyeurope.com/news/250m-wasted-on-ineffective-drugs/ 2025-01-20T13:28:20+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/GettyImages-871424916.jpg https://hospitalpharmacyeurope.com/news/drugs-giant-confident-around-cuts/ 2025-01-20T13:28:21+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/GettyImages-871424916.jpg https://hospitalpharmacyeurope.com/news/45m-in-savings-on-offer-to-the-nhs-with-galen-trustsaver-collection/ 2025-01-20T13:28:21+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/GettyImages-871424916.jpg https://hospitalpharmacyeurope.com/news/h1n1-vaccine-deal-struck-with-glaxo/ 2025-01-20T13:28:22+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/03/infectious-disease-965x500.jpg https://hospitalpharmacyeurope.com/news/9m-cut-in-prescription-spending/ 2025-01-20T13:28:23+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/GettyImages-871424916.jpg https://hospitalpharmacyeurope.com/news/cost-of-medicine-will-not-rise/ 2025-01-20T13:28:24+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/GettyImages-871424916.jpg https://hospitalpharmacyeurope.com/reviews-research/drug-giants-seek-help-to-cut-costs/ 2025-01-20T13:28:25+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2016/08/Medicines-reconciliation-4.jpg https://hospitalpharmacyeurope.com/news/drug-makers-growth-offset-by-costs/ 2025-01-20T13:28:25+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/GettyImages-871424916.jpg https://hospitalpharmacyeurope.com/news/ireland-slashes-cost-of-medicines/ 2025-01-20T13:28:26+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/GettyImages-871424916.jpg https://hospitalpharmacyeurope.com/news/scottish-prescription-prices-fall/ 2025-01-20T13:28:27+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/GettyImages-871424916.jpg https://hospitalpharmacyeurope.com/news/12bn-nhs-it-programme-facing-cuts/ 2025-01-20T13:28:28+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/GettyImages-871424916.jpg https://hospitalpharmacyeurope.com/news/nice-could-save-nhs-600-million/ 2025-01-20T13:28:29+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/GettyImages-871424916.jpg https://hospitalpharmacyeurope.com/news/tories-call-for-nhs-pricing-reform/ 2025-01-20T13:28:30+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/GettyImages-871424916.jpg https://hospitalpharmacyeurope.com/news/gavi-forces-down-vaccine-price/ 2025-01-20T13:29:35+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/05/GettyImages-1126063131.jpg https://hospitalpharmacyeurope.com/news/warning-over-prescription-costs/ 2025-01-20T13:29:36+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/GettyImages-871424916.jpg https://hospitalpharmacyeurope.com/news/glaxo-set-for-1bn-vaccine-boost/ 2025-01-20T13:29:37+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/05/GettyImages-1126063131.jpg https://hospitalpharmacyeurope.com/news/technology-could-save-wasted-money/ 2025-01-20T13:29:37+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/GettyImages-871424916.jpg https://hospitalpharmacyeurope.com/news/chantix-slash-costs/ 2025-01-20T13:29:38+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/GettyImages-871424916.jpg https://hospitalpharmacyeurope.com/news/arpida-reduce-cash-burn/ 2025-01-20T13:29:39+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/GettyImages-871424916.jpg https://hospitalpharmacyeurope.com/news/deal-to-supply-cut-price-hiv-drugs/ 2025-01-20T13:29:40+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/GettyImages-871424916.jpg https://hospitalpharmacyeurope.com/news/philippines-slashes-drug-prices/ 2025-01-20T13:29:41+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/GettyImages-871424916.jpg https://hospitalpharmacyeurope.com/news/prescription-numbers-up-cost-down/ 2025-01-20T13:29:41+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2015/10/Medicines-reconciliation-3.jpg https://hospitalpharmacyeurope.com/news/innovative-drugs-to-bypass-regulator/ 2025-01-20T13:29:42+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/GettyImages-871424916.jpg https://hospitalpharmacyeurope.com/news/patients-blinkered-over-drugs/ 2025-01-20T13:29:43+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/GettyImages-871424916.jpg https://hospitalpharmacyeurope.com/news/recession-challenge-for-nhs/ 2025-01-20T13:29:44+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/GettyImages-871424916.jpg https://hospitalpharmacyeurope.com/news/prescription-refund-given-to-welsh/ 2025-01-20T13:29:44+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/GettyImages-871424916.jpg https://hospitalpharmacyeurope.com/news/deuterium-fuels-1-billion-deal/ 2025-01-20T13:29:45+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/GettyImages-871424916.jpg https://hospitalpharmacyeurope.com/news/crisis-across-the-continent/ 2025-01-20T13:29:46+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/GettyImages-871424916.jpg https://hospitalpharmacyeurope.com/clinical-zones/haematology/blood-clot-drug-is-cost-effective/ 2025-01-20T13:29:47+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/07/haematology-2.jpg https://hospitalpharmacyeurope.com/news/insightec-ltd-announces-us15-million-investment-round/ 2025-01-20T13:29:48+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/GettyImages-871424916.jpg https://hospitalpharmacyeurope.com/news/merck-kgaa-bloom-despite-current-economic-state/ 2025-01-20T13:29:49+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/GettyImages-871424916.jpg https://hospitalpharmacyeurope.com/news/drug-company-enters-bond-market/ 2025-01-20T13:29:49+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/GettyImages-871424916.jpg https://hospitalpharmacyeurope.com/news/gsk-cutting-drug-costs-to-help-poor/ 2025-01-20T13:29:50+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/GettyImages-871424916.jpg https://hospitalpharmacyeurope.com/news/glaxo-cutting-jobs-to-save-1bn/ 2025-01-20T13:29:51+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/GettyImages-871424916.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/cancer-drugs-to-be-funded-in-wales/ 2025-01-20T13:29:52+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/08/Oncology-1.jpg https://hospitalpharmacyeurope.com/news/regulator-funded-by-drug-firms/ 2025-01-20T13:29:53+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/GettyImages-871424916.jpg https://hospitalpharmacyeurope.com/news/price-of-drugs-boosts-us-market/ 2025-01-20T13:29:54+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/GettyImages-871424916.jpg https://hospitalpharmacyeurope.com/news/millions-shaved-off-nhs-drugs-bill/ 2025-01-20T13:29:54+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/GettyImages-871424916.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/roche-defends-costs-of-cancer-drug/ 2025-01-20T13:29:55+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/GettyImages-871424916.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/cancer-drug-in-nhs-price-cut-bid/ 2025-01-20T13:29:56+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/08/Oncology-1.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/nice-in-trouble-over-value-for-money-cancer-drug-decisions/ 2025-01-20T13:29:57+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/GettyImages-871424916.jpg https://hospitalpharmacyeurope.com/news/cheaper-competition-threatens-gsk/ 2025-01-20T13:29:57+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/GettyImages-871424916.jpg https://hospitalpharmacyeurope.com/news/companies-driving-up-drug-prices/ 2025-01-20T13:29:58+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/GettyImages-871424916.jpg https://hospitalpharmacyeurope.com/news/drug-cash-funding-other-services/ 2025-01-20T13:29:59+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/GettyImages-871424916.jpg https://hospitalpharmacyeurope.com/news/agreement-reached-on-drug-pricing/ 2025-01-20T13:30:00+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/GettyImages-871424916.jpg https://hospitalpharmacyeurope.com/news/drug-endorsement-fees-criticised/ 2025-01-20T13:30:01+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/GettyImages-871424916.jpg https://hospitalpharmacyeurope.com/news/uk-prescription-costs-to-rise-by-25p/ 2025-01-20T13:30:02+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/GettyImages-871424916.jpg https://hospitalpharmacyeurope.com/news/drug-supply-cost-cutting-drive-hailed/ 2025-01-20T13:30:02+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/GettyImages-871424916.jpg https://hospitalpharmacyeurope.com/news/pharmacy-services-to-be-disrupted/ 2025-01-20T13:30:03+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/GettyImages-871424916.jpg https://hospitalpharmacyeurope.com/news/placebo-effect-influenced-by-cost/ 2025-01-20T13:30:04+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/GettyImages-871424916.jpg https://hospitalpharmacyeurope.com/news/call-to-reform-prescription-charges/ 2025-01-20T13:30:05+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/GettyImages-871424916.jpg https://hospitalpharmacyeurope.com/news/pharmacy-contract-spending-defended/ 2025-01-20T13:30:06+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/GettyImages-871424916.jpg https://hospitalpharmacyeurope.com/news/probe-finds-uks-nice-has-room-for-improvement/ 2025-01-20T13:30:07+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/GettyImages-871424916.jpg https://hospitalpharmacyeurope.com/news/mps-concerned-over-nice-approvals/ 2025-01-20T13:30:08+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/GettyImages-871424916.jpg https://hospitalpharmacyeurope.com/news/scotland-scraps-prescription-charge/ 2025-01-20T13:30:09+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/GettyImages-871424916.jpg https://hospitalpharmacyeurope.com/news/drug-deals-spark-cost-rise-concerns/ 2025-01-20T13:30:09+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/GettyImages-871424916.jpg https://hospitalpharmacyeurope.com/news/german-cutbacks-complete-as-astrazeneca-sells-facility/ 2025-01-20T13:30:10+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/GettyImages-871424916.jpg https://hospitalpharmacyeurope.com/news/54m-for-scottish-hospitals/ 2025-01-20T13:30:11+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/GettyImages-871424916.jpg https://hospitalpharmacyeurope.com/news/renal-patient-refused-sunitinib-due-to-cost/ 2025-01-20T13:30:12+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/07/Nephrology-2.jpg https://hospitalpharmacyeurope.com/news/prescription-charge-plan-imminent/ 2025-01-20T13:30:12+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/GettyImages-871424916.jpg https://hospitalpharmacyeurope.com/news/cancer-drug-refused-due-to-cost/ 2025-01-20T13:30:13+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/GettyImages-871424916.jpg https://hospitalpharmacyeurope.com/news/minister-in-bid-to-scrap-prescriptions/ 2025-01-20T13:30:14+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/GettyImages-871424916.jpg https://hospitalpharmacyeurope.com/news/prescriptions-bill-doubles-in-scotland/ 2025-01-20T13:30:15+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/GettyImages-871424916.jpg https://hospitalpharmacyeurope.com/news/drug-firms-warned-to-adapt-to-care-delivery-changes/ 2025-01-20T13:30:49+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/GettyImages-871424916.jpg https://hospitalpharmacyeurope.com/news/ireland-tightens-drug-expenditure/ 2025-01-20T13:30:50+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/GettyImages-871424916.jpg https://hospitalpharmacyeurope.com/news/us-price-control-bid-rejected/ 2025-01-20T13:30:51+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/GettyImages-871424916.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/uk-patient-slams-velcade-policy/ 2025-01-20T13:30:51+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/GettyImages-871424916.jpg https://hospitalpharmacyeurope.com/news/generics-market-set-to-grow/ 2025-01-20T13:30:52+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/GettyImages-871424916.jpg https://hospitalpharmacyeurope.com/news/warning-on-drug-price-rules/ 2025-01-20T13:30:53+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/GettyImages-871424916.jpg https://hospitalpharmacyeurope.com/news/big-pharma-big-prices/ 2025-01-20T13:30:54+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/GettyImages-871424916.jpg https://hospitalpharmacyeurope.com/news/warning-on-uk-value-based-pricing/ 2025-01-20T13:30:55+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/GettyImages-871424916.jpg https://hospitalpharmacyeurope.com/news/california-budget-threat-to-pharmacies/ 2025-01-20T13:30:55+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/GettyImages-871424916.jpg https://hospitalpharmacyeurope.com/news/study-shows-uk-drug-prices-7-below-eu-average/ 2025-01-20T13:30:56+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/GettyImages-871424916.jpg https://hospitalpharmacyeurope.com/news/investing-in-medicine-management-technology/ 2025-01-20T13:30:57+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/GettyImages-871424916.jpg https://hospitalpharmacyeurope.com/news/the-different-costs-of-high-technology-medicines/ 2025-01-20T13:30:58+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/GettyImages-871424916.jpg https://hospitalpharmacyeurope.com/news/pda-based-audit-of-pharmacist-interventions/ 2025-01-20T13:30:59+00:00 https://hospitalpharmacyeurope.com/clinical-zones/rheumatology/pharmacoeconomics-of-rheumatoid-arthritis-drugs/ 2025-01-20T13:31:00+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2003/01/Rheumatology-3.jpg https://hospitalpharmacyeurope.com/news/hiv-costs-individual-and-population-perspectives/ 2025-01-20T13:31:00+00:00 https://hospitalpharmacyeurope.com/clinical-zones/neurology/pharmacoeconomics-of-alzheimers-disease/ 2025-01-20T13:31:01+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2002/09/Palliactive-care-2.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/reduced-risk-of-long-covid-linked-to-metformin-use/ 2025-01-20T13:32:49+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/06/Reduced_risk_of_long_Covid_linked_to_metformin_use.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/large-study-finds-no-increased-risk-of-menstrual-changes-after-covid-vaccination/ 2025-01-20T13:32:51+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/05/Large_study_finds_no_increased_risk_of_menstrual_changes_after_Covid_vaccination.jpg https://hospitalpharmacyeurope.com/news/covid-19-global-health-emergency-over-but-threat-remains-says-who/ 2025-01-20T13:32:52+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/05/Covid_19_global_health_emergency_over_but_threat_remains_says_WHO.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/fluvoxamine-and-inhaled-budesonide-combination-reduces-disease-progression-in-covid-19/ 2025-01-20T13:32:53+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/04/Fluvoxamine-and-inhaled-budesonide-combination-reduces-disease-progression-in-COVID-19.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/lagevrio-refused-marketing-authorisation-by-ema-for-treatment-of-covid/ 2025-01-20T13:32:54+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/02/Lagevrio-refused-marketing-authorisation-by-EMA-for-treatment-of-COVID.jpg https://hospitalpharmacyeurope.com/clinical-zones/immunology/prior-covid-19-infection-offers-a-similar-protection-as-two-doses-of-a-mrna-vaccine/ 2025-01-20T13:32:55+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/02/Prior-COVID-19-infection-offers-a-similar-protection-as-two-doses-of-a-mRNA-vaccine.jpg https://hospitalpharmacyeurope.com/clinical-zones/immunology/waning-covid-19-vaccine-effectiveness-indicates-need-for-continued-preventative-measures/ 2025-01-20T13:32:56+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/02/Waning-COVID-19-vaccine-effectiveness-indicates-need-for-continued-preventative-measures.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/jcvi-provides-advice-on-next-round-of-covid-booster-vaccinations/ 2025-01-20T13:32:57+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/01/JCVI-provides-advice-on-next-round-of-Covid-booster-vaccinations.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/heart-failure-risk-significantly-elevated-after-covid-19-infection/ 2025-01-20T13:32:58+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/01/Heart-failure-risk-significantly-elevated-after-COVID-19-infection.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/remdesivir-treatment-produces-improvement-in-covid-19-severity-biomarkers/ 2025-01-20T13:32:59+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/01/Remdesivir-treatment-produces-improvement-in-COVID-19-severity-biomarkers.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/anti-cd20-therapy-linked-to-higher-complication-risk-in-covid-19-for-blood-cancer-patients/ 2025-01-20T13:32:59+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/01/Anti-CD20-therapy-linked-to-higher-complication-risk-in-COVID-19-for-blood-cancer-patients.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/trial-finds-molnupiravir-treatment-unable-to-reduce-adverse-covid-19-outcomes-among-high-risk-vaccinated-patients/ 2025-01-20T13:33:00+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/01/Trial-finds-molnupiravir-treatment-unable-to-reduce-adverse-COVID-19-outcomes-among-high-risk-vaccinated-patients.gif https://hospitalpharmacyeurope.com/clinical-zones/respiratory/favipiravir-only-benefits-recovery-in-younger-patients-hospitalised-with-covid-19/ 2025-01-20T13:33:01+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/01/Favipiravir-only-benefits-recovery-in-younger-patients-hospitalised-with-COVID-19.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/not-all-post-covid-19-condition-symptoms-are-specific-to-the-virus/ 2025-01-20T13:33:02+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/01/Not-all-post-COVID-19-condition-symptoms-are-specific-to-the-virus.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/vaccination-decreases-risk-for-development-of-post-covid-19-condition/ 2025-01-20T13:33:03+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/12/Vaccination-decreases-risk-for-development-of-post-COVID-19-condition.gif https://hospitalpharmacyeurope.com/clinical-zones/oncology/higher-levels-of-advanced-colorectal-cancer-detected-during-covid-19/ 2025-01-20T13:33:04+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/12/Higher-levels-of-advanced-colorectal-cancer-detected-during-COVID-19.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/nirmatrelvir-and-ritonavir-combination-appears-safe-in-pregnancy/ 2025-01-20T13:33:05+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/12/Nirmatrelvir-and-ritonavir-combination-appears-safe-in-pregnancy.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/rct-finds-telmisartan-no-better-than-placebo-in-patients-hospitalised-with-covid-19/ 2025-01-20T13:33:06+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/11/RCT-finds-telmisartan-no-better-than-placebo-in-patients-hospitalised-with-COVID-19.gif https://hospitalpharmacyeurope.com/clinical-zones/respiratory/myocarditis-rate-much-higher-in-younger-patients-after-mrna-vaccination/ 2025-01-20T13:33:06+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/11/Myocarditis-rate-much-higher-in-younger-patients-after-mRNA-vaccination.gif https://hospitalpharmacyeurope.com/clinical-zones/respiratory/post-covid-19-condition-symptoms-persists-for-at-least-2-years/ 2025-01-20T13:33:07+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/11/Post-COVID-19-condition-symptoms-persists-for-at-least-2-years.gif https://hospitalpharmacyeurope.com/clinical-zones/respiratory/serum-vitamin-d-levels-might-protect-against-infection-with-covid-19/ 2025-01-20T13:33:09+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/11/Serum-vitamin-D-levels-might-protect-against-infection-with-COVID-19.gif https://hospitalpharmacyeurope.com/clinical-zones/respiratory/tixagevimab-cilgavimab-effective-against-adverse-outcomes-for-immunocompromised/ 2025-01-20T13:33:10+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/11/Tixagevimab-cilgavimab-effective-against-adverse-outcomes-for-immunocompromised.gif https://hospitalpharmacyeurope.com/clinical-zones/immunology/covid-19-vaccine-confidence-declined-since-pandemic/ 2025-01-20T13:33:11+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/11/COVID-19-vaccine-confidence-declined-since-pandemic.gif https://hospitalpharmacyeurope.com/clinical-zones/respiratory/omicron-ba-2-sub-variant-causes-less-severe-disease/ 2025-01-20T13:33:12+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/11/Omicron-BA.2-sub-variant-causes-less-severe-disease.gif https://hospitalpharmacyeurope.com/clinical-zones/immunology/mrna-1273-vaccine-response-in-children-from-6-months-non-inferior-to-young-adults/ 2025-01-20T13:33:13+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/11/mRNA-1273-vaccine-response-in-children-from-6-months-non-inferior-to-young-adults.gif https://hospitalpharmacyeurope.com/clinical-zones/respiratory/adverse-cardiovascular-outcomes-highest-for-patients-hospitalised-with-covid-19/ 2025-01-20T13:33:13+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/11/Adverse-cardiovascular-outcomes-highest-for-patients-hospitalised-with-COVID-19.gif https://hospitalpharmacyeurope.com/clinical-zones/immunology/antibody-response-from-omicron-ba-4-ba-5-bivalent-booster-no-better-than-original-vaccine/ 2025-01-20T13:33:14+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/10/Antibody-response-from-Omicron-BA.4-BA.5-bivalent-booster-no-better-than-original-vaccine.gif https://hospitalpharmacyeurope.com/clinical-zones/respiratory/remdesivir-recovery-benefits-similar-to-standard-care-following-covid-19/ 2025-01-20T13:33:15+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/10/Remdesivir-recovery-benefits-similar-to-standard-care-following-COVID-19.jpg https://hospitalpharmacyeurope.com/clinical-zones/immunology/omicron-ba-4-ba-5-adapted-bivalent-vaccine-generates-higher-antibody-response/ 2025-01-20T13:33:16+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/10/Omicron-BA.4-BA.5-adapted-bivalent-vaccine-generates-higher-antibody-response.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/molnupiravir-treatment-reduces-recovery-time-in-high-risk-vaccinated-patients/ 2025-01-20T13:33:17+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/10/Molnupiravir-treatment-reduces-recovery-time-in-high-risk-vaccinated-patients.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/11-of-patients-still-not-recovered-18-months-after-covid-19-infection/ 2025-01-20T13:33:17+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/10/11-of-patients-still-not-recovered-18-months-after-COVID-19-infection.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/remdesivir-benefits-haemodialysis-patients-with-covid-19/ 2025-01-20T13:33:18+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/10/Remdesivir-benefits-haemodialysis-patients-with-COVID-19.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/some-covid-19-variants-not-neutralised-by-evusheld/ 2025-01-20T13:33:19+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/10/Some-COVID-19-variants-not-neutralised-by-Evusheld.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/alzheimers-disease-risk-elevated-among-older-adults-with-covid-19/ 2025-01-20T13:33:20+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/09/Alzheimers-disease-risk-elevated-among-older-adults-with-COVID-19.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/rct-examined-effectiveness-of-high-flow-nasal-cannula-oxygen-on-covid-19-mortality/ 2025-01-20T13:33:20+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/09/RCT-examined-effectiveness-of-high-flow-nasal-cannula-oxygen-on-COVID-19-mortality.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/risk-of-new-onset-type1-diabetes-in-children-and-adolescents-higher-after-covid-19-infection/ 2025-01-20T13:33:21+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/09/Risk-of-new-onset-type1-diabetes-in-children-and-adolescents-higher-after-COVID-19-infection.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/vitamin-d-supplementation-ineffective-for-prevention-of-acute-respiratory-infection-or-covid-19/ 2025-01-20T13:33:22+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/09/Vitamin-D-supplementation-ineffective-for-prevention-of-acute-respiratory-infection-or-COVID-19.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/male-hypogonadism-an-independent-risk-factor-for-hospitalisation-in-covid-19/ 2025-01-20T13:33:23+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/09/Male-hypogonadism-an-independent-risk-factor-for-hospitalisation-in-COVID-19.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/review-suggests-incubation-time-for-covid-19-variants-shorter-than-original/ 2025-01-20T13:33:24+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/09/Review-suggests-shortening-incubation-time-for-COVID-19-variants.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/no-benefit-for-covid-19-inpatients-from-colchicine-or-aspirin-and-rivaroxaban-combined/ 2025-01-20T13:33:24+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/09/No-benefit-for-COVID-19-inpatients-from-colchicine-or-aspirin-and-rivaroxaban-combined.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/limited-benefit-from-nirmatrelvir-against-omicron-related-hospitalisation-in-patients-under-65/ 2025-01-20T13:33:25+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/08/Limited-benefit-from-nirmatrelvir-against-omicron-related-hospitalisation-in-patients-under-65.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/review-finds-greater-regular-physical-activity-lowers-risk-of-adverse-covid-19-outcomes/ 2025-01-20T13:33:26+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/08/Review-finds-greater-regular-physical-activity-lowers-risk-of-adverse-COVID-19-outcomes.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/triple-dose-covid-19-vaccination-lowers-risk-of-developing-long-covid/ 2025-01-20T13:33:27+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/08/Triple-dose-COVID-19-vaccination-lowers-risk-of-developing-long-covid.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/hypertension-persists-as-significant-risk-factor-for-severe-covid-19-in-fully-vaccinated/ 2025-01-20T13:33:28+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/08/Hypertension-persists-as-significant-risk-factor-for-severe-COVID-19-in-fully-vaccinated.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/young-children-reduce-covid-disease-severity-in-parents/ 2025-01-20T13:33:29+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/08/Young-children-reduce-COVID-disease-severity-in-parents.jpg https://hospitalpharmacyeurope.com/clinical-zones/immunology/bivalent-covid-19-booster-vaccine-receives-mrha-approval/ 2025-01-20T13:33:29+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/08/Bivalent-COVID-19-booster-vaccine-receives-MRHA-approval.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/covid-19-vaccination-reduces-mi-and-stroke-related-infection-risk/ 2025-01-20T13:33:30+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/08/COVID-19-vaccination-reduces-MI-and-stroke-related-infection-risk.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/resistance-mutations-develop-in-patients-given-sotrovimab-infected-with-omicron-variants/ 2025-01-20T13:34:22+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/08/Resistance-mutations-develop-in-patients-given-sotrovimab-infected-with-omicron-variants.jpg https://hospitalpharmacyeurope.com/clinical-zones/paediatrics/a-quarter-of-children-found-to-develop-long-covid/ 2025-01-20T13:34:23+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/08/A-quarter-of-children-found-to-develop-long-covid.jpg https://hospitalpharmacyeurope.com/clinical-zones/immunology/ultrasound-ai-distinguishes-between-metastatic-and-covid-vaccine-related-lymph-node-changes/ 2025-01-20T13:34:24+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/07/Ultrasound-AI-distinguishes-between-metastatic-and-covid-vaccine-related-lymph-node-changes.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/post-covid-19-diabetes-risk-remains-high-for-three-months/ 2025-01-20T13:34:25+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/07/Post-COVID-19-diabetes-risk-remains-high-for-three-months.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/omicron-infection-less-likely-than-delta-to-cause-long-covid/ 2025-01-20T13:34:25+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/07/Omicron-infection-less-likely-than-Delta-to-cause-long-covid.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/oral-sabizabulin-reduces-mortality-in-hospitalised-patients-with-covid-19/ 2025-01-20T13:34:26+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/07/Oral-sabizabulin-reduces-mortality-in-hospitalised-patients-with-COVID-19.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/intermittent-fasting-lowers-rates-of-covid-19-hospitalisation-and-death/ 2025-01-20T13:34:27+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/07/Intermittent-fasting-lowers-rates-of-COVID-19-hospitalisation-and-death.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/vaccinating-overweight-and-obese-protects-against-against-severe-covid-19-and-death/ 2025-01-20T13:34:28+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/07/Vaccinating-overweight-and-obese-protects-against-against-severe-COVID-19-and-death.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/cardiometabolic-and-social-factors-combined-offer-better-prediction-of-covid-19-outcomes/ 2025-01-20T13:34:28+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/07/Cardiometabolic-and-social-factors-combined-offer-better-prediction-of-COVID-19-outcomes.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/cancer-screening-reduced-significantly-during-covid-19-pandemic/ 2025-01-20T13:34:29+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/07/Cancer-screening-reduced-significantly-during-COVID-19-pandemic.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/spike-protein-persisting-in-blood-might-account-for-long-covid-symptoms/ 2025-01-20T13:34:30+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/07/Spike-protein-persisting-in-blood-might-account-for-long-covid-symptoms.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/statin-use-associated-with-reduced-risk-of-hospitalisation-and-death-from-covid-19/ 2025-01-20T13:34:31+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/07/Statin-use-associated-with-reduced-risk-of-hospitalisation-and-death-from-COVID-19.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/methotrexate-suspension-for-2-weeks-after-covid-19-vaccination-boosts-antibody-response/ 2025-01-20T13:34:32+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/06/Methotrexate-suspension-for-2-weeks-after-COVID-19-vaccination-boosts-antibody-response.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/paxlovid-effective-among-vaccinated-individuals/ 2025-01-20T13:34:32+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/06/Paxlovid-effective-among-vaccinated-individuals.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/ct-chest-changes-less-severe-with-omicron-compared-to-delta-infection/ 2025-01-20T13:34:33+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/06/CT-chest-changes-less-severe-with-omicron-compared-to-delta-infection.jpg https://hospitalpharmacyeurope.com/clinical-zones/immunology/bivalent-moderna-vaccine-effective-against-omicron-sub-variants/ 2025-01-20T13:34:34+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/06/Bivalent-Moderna-vaccine-effective-against-Omicron-sub-variants.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/rct-finds-single-dose-of-evusheld-reduces-progression-of-covid-19-and-mortality/ 2025-01-20T13:34:35+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/06/RCT-finds-single-dose-of-Evusheld-reduces-progression-of-COVID-19-and-mortality.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/paxlovid-no-better-than-placebo-for-low-risk-patients-with-covid-19/ 2025-01-20T13:34:36+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/06/PAXLOVID-no-better-than-placebo-for-low-risk-patients-with-COVID-19.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/vitamin-d-status-shows-inconsistent-associations-with-covid-19-infection/ 2025-01-20T13:34:37+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/06/Vitamin-D-status-shows-inconsistent-associations-with-COVID-19-infection.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/added-clinical-benefits-of-molnupiravir-in-covid-19-possible/ 2025-01-20T13:34:37+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/06/Added-clinical-benefits-of-molnupiravir-in-COVID-19-possible.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/hormone-replacement-therapy-use-associated-with-reduced-mortality-risk-from-covid-19/ 2025-01-20T13:34:38+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/06/Hormone-replacement-therapy-use-associated-with-reduced-mortality-risk-from-COVID-19.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/meta-analysis-finds-vasopressor-use-in-critically-ill-covid-19-patients-linked-to-higher-mortality/ 2025-01-20T13:34:39+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/05/Meta-analysis-finds-vasopressor-use-in-critically-ill-COVID-19-patients-linked-to-higher-mortality.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/fourth-covid-19-vaccination-effectiveness-drops-after-only10-weeks/ 2025-01-20T13:34:40+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/05/Fourth-COVID-19-vaccination-effectiveness-drops-after-only10-weeks.jpg https://hospitalpharmacyeurope.com/clinical-zones/immunology/oral-aerosolised-covid-19-booster-dose-produces-high-antibody-levels/ 2025-01-20T13:34:41+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/05/Oral-aerosolised-COVID-19-booster-dose-produces-high-antibody-levels.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/multi-inflammatory-index-best-predictor-of-mortality-in-icu-covid-19-patients/ 2025-01-20T13:34:42+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/05/Multi-inflammatory-index-best-predictor-of-mortality-in-ICU-COVID-19-patients.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/study-finds-scent-dogs-accurately-identify-patients-infected-with-covid-19/ 2025-01-20T13:34:42+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/05/Study-finds-scent-dogs-accurately-identify-patients-infected-with-COVID-19.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/study-finds-eno-breathe-programme-improves-mental-wellbeing-and-breathlessness-upon-running-in-long-covid/ 2025-01-20T13:34:43+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/05/Study-finds-ENO-Breathe-programme-improves-mental-wellbeing-and-breathlessness-upon-running-in-long-covid.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/degarelix-induced-androgen-suppression-does-not-improve-outcomes-in-men-hospitalised-with-covid-19/ 2025-01-20T13:34:44+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/04/Degarelix-induced-androgen-suppression-does-not-improve-outcomes-in-men-hospitalised-with-COVID-19.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/fourth-covid-19-vaccination-offers-greater-protection-against-adverse-covid-19-related-outcomes/ 2025-01-20T13:34:45+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/04/Fourth-COVID-19-vaccination-offers-greater-protection-against-adverse-COVID-19-related-outcomes.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/bnt162b-vaccination-lowers-risk-of-omicron-associated-hospitalisation-in-children-by-two-thirds/ 2025-01-20T13:34:46+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/04/BNT162b-vaccination-lowers-risk-of-omicron-associated-hospitalisation-in-children-by-two-thirds.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/cognitive-impairment-present-6-months-after-acute-covid-19-infection/ 2025-01-20T13:34:47+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/04/Cognitive-impairment-present-6-months-after-acute-COVID-19-infection.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/pre-existing-hypertension-not-an-independent-risk-factor-for-in-hospital-covid-19-mortality/ 2025-01-20T13:34:47+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/04/Pre-existing-hypertension-not-an-independent-risk-factor-for-in-hospital-COVID-19-mortality.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/study-finds-convalescent-plasma-use-in-unvaccinated-covid-19-patients-reduces-hospitalisation/ 2025-01-20T13:34:48+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/04/Study-finds-convalescent-plasma-use-in-unvaccinated-COVID-19-patients-reduces-hospitalisation.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/remdesivir-use-in-covid-19-patients-requiring-ventilator-support-no-better-than-standard-care/ 2025-01-20T13:34:49+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/04/Remdesivir-use-in-COVID-19-patients-requiring-ventilator-support-no-better-than-standard-care.jpg https://hospitalpharmacyeurope.com/clinical-zones/paediatrics/low-incidence-of-covid-19-positivity-in-babies-of-infected-mothers/ 2025-01-20T13:34:50+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/04/Low-incidence-of-COVID-19-positivity-in-babies-of-infected-mothers.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/prone-positioning-unhelpful-for-non-critically-ill-covid-19-patients/ 2025-01-20T13:34:50+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/04/Prone-positioning-unhelpful-for-non-critically-ill-COVID-19-patients-1.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/early-ivermectin-use-fails-to-prevent-worsening-of-covid-19/ 2025-01-20T13:34:51+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/04/Early-ivermectin-use-fails-to-prevent-worsening-of-COVID-19.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/tixagevimab-cilgavimab-evusheld-combination-approved-by-mhra-for-covid-19-prevention/ 2025-01-20T13:34:52+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/03/Tixagevimab-cilgavimab-Evusheld-combination-approved-by-MHRA-for-COVID-19-prevention.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/following-the-science/ 2025-01-20T13:34:53+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/03/Following-the-science.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/type-2-diabetes-risk-increased-by-50-after-covid-19-infection/ 2025-01-20T13:34:54+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/03/Type-2-diabetes-risk-increased-by-50-after-COVID-19-infection.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/losartan-of-no-benefit-for-covid-19-patients-with-lung-injury/ 2025-01-20T13:34:55+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/03/Losartan-shows-no-benefit-for-COVID-19-patients-with-lung-injury.jpg https://hospitalpharmacyeurope.com/clinical-zones/mental-health/increased-opioid-agonist-therapy-take-home-during-covid-19-associated-with-reduced-incidence-of-overdose/ 2025-01-20T13:34:55+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/03/Increased-opioid-agonist-therapy-take-home-during-COVID-19-associated-with-reduced-incidence-of-overdose.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/exonuclease-and-polymerase-inhibitor-combination-a-possible-treatment-for-covid-19/ 2025-01-20T13:34:56+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/03/Exonuclease-and-polymerase-inhibitor-combination-a-possible-treatment-for-COVID-19.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/seroconversion-rates-low-among-immunocompromised-patients-after-covid-19-vaccination/ 2025-01-20T13:34:57+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/03/Seroconversion-rates-low-among-immunocompromised-patients-after-COVID-19-vaccination.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/baricitinib-reduces-mortality-in-covid-19-by-13-according-to-recovery-trial/ 2025-01-20T13:34:58+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/03/Baricitinib-reduces-mortality-in-COVID-19-by-13-according-to-RECOVERY-trial.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/risk-assessment-tools-improve-emergency-medical-service-staff-triage-for-suspected-covid-19/ 2025-01-20T13:34:59+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/02/Risk-assessment-tools-improve-emergency-medical-service-staff-triage-for-suspected-COVID-19.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/auditory-symptoms-association-with-covid-19-could-be-spurious/ 2025-01-20T13:34:59+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/02/Auditory-symptoms-association-with-COVID-19-could-be-spurious-1.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/oral-bolus-of-vitamin-d-upon-hospital-at-admission-has-not-effect-on-covid-19-outcomes/ 2025-01-20T13:35:00+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/02/Oral-bolus-of-vitamin-D-upon-hospital-at-admission-has-not-effect-on-COVID-19-outcomes.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/cardiovascular-disease-burden-huge-after-covid-19-infection/ 2025-01-20T13:35:01+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/02/Cardiovascular-disease-burden-huge-after-COVID-19-infection.jpg https://hospitalpharmacyeurope.com/clinical-zones/mental-health/mental-health-disorders-risk-higher-following-an-acute-covid-19-infection/ 2025-01-20T13:35:02+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/02/Mental-health-disorders-risk-higher-following-an-acute-COVID-19-infection.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/oral-nirmatrelivir-and-ritonavir-reduce-risk-of-covid-19-progression-by-89/ 2025-01-20T13:35:33+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/02/Oral-nirmatrelivir-and-ritonavir-reduce-risk-of-COVID-19-progression-by-89.jpg https://hospitalpharmacyeurope.com/clinical-zones/immunology/allergic-rhinitis-symptoms-worsened-for-40-of-patients-during-covid-19-lockdown/ 2025-01-20T13:35:34+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/02/Allergic-rhinitis-symptoms-worsened-for-40-of-patients-during-COVID-19-lockdown.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/computer-modelling-identifies-potential-drug-treatments-for-covid-19/ 2025-01-20T13:35:36+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/02/Computer-modelling-identifies-potential-drug-treatments-for-COVID-19.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/oestrogen-supplementation-linked-to-lower-covid-19-death-rate/ 2025-01-20T13:35:37+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/02/Oestrogen-supplementation-linked-to-lower-COVID-19-death-rate.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/re-hospitalisation-and-risk-of-death-higher-among-covid-19-patients-compared-to-general-population/ 2025-01-20T13:35:38+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/02/Re-hospitalisation-and-risk-of-death-higher-among-COVID-19-patients-compared-to-general-population.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/obstetric-complications-more-common-among-women-with-covid-19/ 2025-01-20T13:35:38+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/02/Obstetric-complications-more-common-among-women-with-COVID-19.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/niclosamide-equivalent-to-placebo-at-oropharyngeal-clearance-of-covid-19/ 2025-01-20T13:35:39+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/02/Niclosamide-equivalent-to-placebo-at-oropharyngeal-clearance-of-COVID-19.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/human-challenge-with-covid-19-provides-valuable-insight-of-infection-dynamics/ 2025-01-20T13:35:40+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/02/Human-challenge-with-COVID-19-provides-valuable-insight-of-infection-dynamics.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/vitamin-d-deficient-patients-significantly-more-likely-to-get-severe-covid-19/ 2025-01-20T13:35:41+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/02/Vitamin-D-deficient-patients-significantly-more-likely-to-get-severe-COVID-19.jpg https://hospitalpharmacyeurope.com/clinical-zones/immunology/blood-cancer-patients-produce-lower-antibody-response-to-omicron-despite-third-covid-vaccine/ 2025-01-20T13:35:42+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/02/Blood-cancer-patients-produce-lower-antibody-response-to-Omicron-despite-third-covid-vaccine.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/p2y12-inhibitor-add-on-to-heparin-of-no-benefit-in-non-critically-ill-covid-19-patients/ 2025-01-20T13:35:43+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/01/P2Y12-inhibitor-add-on-to-heparin-of-no-benefit-in-non-critically-ill-COVID-19-patients.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/omicron-covid-variant-remains-viable-on-human-skin-for-21-hours/ 2025-01-20T13:35:43+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/02/Omicron-Covid-variant-remains-viable-on-human-skin-for-21-hours-2.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/casirivimab-and-imdevimab-reduce-incidence-of-symptomatic-covid-19/ 2025-01-20T13:35:44+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/01/Casirivimab-and-imdevimab-reduce-incidence-of-symptomatic-COVID-19.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/booster-covid-19-vaccination-increases-immune-response-in-cancer-patients-on-active-treatment/ 2025-01-20T13:35:45+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/01/GettyImages-1334441038.jpg-covid-booster-shot.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/atorvastatin-comparable-to-placebo-for-covid-19-patients-in-icu/ 2025-01-20T13:35:46+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/01/GettyImages-1223596953.jpg-statins.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/vaccination-found-to-enable-higher-transmission-of-delta-versus-to-alpha-covid-19-variant/ 2025-01-20T13:35:46+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/01/GettyImages-1304835356.jpg-covid-variants.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/cross-reactive-t-cells-protect-against-covid-19-infection/ 2025-01-20T13:35:47+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/01/GettyImages-1206518997.jpg-man-with-cold.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/point-of-care-covid-19-test-in-emergency-department-reduces-turnaround-time/ 2025-01-20T13:35:48+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/01/Point-of-care-COVID-19-test-in-the-ED-reduces-turnaround-time.jpg https://hospitalpharmacyeurope.com/clinical-zones/immunology/third-covid-19-vaccine-dose-only-37-effective-against-omicron-after-7-days/ 2025-01-20T13:35:49+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/01/GettyImages-1357209091.gif-omicron-variant.gif https://hospitalpharmacyeurope.com/clinical-zones/respiratory/molnupiravir-therapy-leads-to-50-lower-hospitalisation-in-unvaccinated-covid-19-patients/ 2025-01-20T13:35:50+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/12/Molnupiravir-therapy-leads-to-50-lower-hospitalisation-in-unvaccinated-COVID-19-patients.jpg https://hospitalpharmacyeurope.com/clinical-zones/dermatology/immunosuppressive-biologics-not-associated-with-increased-risk-of-covid-19-or-mortality/ 2025-01-20T13:35:50+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/01/GettyImages-868766538.gif-immunosuppresive-biologics.gif https://hospitalpharmacyeurope.com/clinical-zones/haematology/sickle-cell-disease-patients-heightened-awareness-of-covid-19-risks-reduced-cases/ 2025-01-20T13:35:51+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/12/GettyImages-1266187249.gif-sickle-cell-disease.gif https://hospitalpharmacyeurope.com/clinical-zones/respiratory/discovery-health-analysis-finds-2-doses-of-bnt162b2-70-effective-against-hospital-admission-during-omicron-variant-outbreak/ 2025-01-20T13:35:52+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/12/GettyImages-1356135876.gif-omicron-variant-discovery-health.gif https://hospitalpharmacyeurope.com/clinical-zones/respiratory/rna-aptamer-binding-to-covid-19-spike-protein-prevents-cellular-entry/ 2025-01-20T13:35:53+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/12/GettyImages-1275267174.gif-RNA-covid.gif https://hospitalpharmacyeurope.com/clinical-zones/oncology/active-disease-in-leukaemia-causes-more-severe-covid-19-and-higher-mortality-in-those-with-a-poor-pre-covid-prognosis-and-neutropenia/ 2025-01-20T13:35:54+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/12/GettyImages-1080830474.gif-active-leukaemia.gif https://hospitalpharmacyeurope.com/clinical-zones/oncology/cancer-clinical-trial-recruitment-drops-by-60-during-pandemic/ 2025-01-20T13:35:56+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/12/HPE-GettyImages-1180547354-ICR-clinical-trials.jpg https://hospitalpharmacyeurope.com/clinical-zones/dermatology/dupilumab-use-in-atopic-eczema-reduces-covid-19-symptom-burden/ 2025-01-20T13:35:56+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/12/GettyImages-669861590.gif-atopic-eczema.gif https://hospitalpharmacyeurope.com/clinical-zones/immunology/mrna-1273-linked-to-lower-risk-of-covid-19-outcomes-than-bnt162b/ 2025-01-20T13:35:57+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/12/GettyImages-1338845788.gif-mRNA-vaccines.gif https://hospitalpharmacyeurope.com/clinical-zones/respiratory/roactemra-tocilizumab-receives-ema-approval-for-severe-covid-19/ 2025-01-20T13:35:58+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/12/GettyImages-1292717571.gif-IL-6.gif https://hospitalpharmacyeurope.com/clinical-zones/respiratory/omicron-variant-could-be-three-times-more-likely-to-cause-re-infection/ 2025-01-20T13:35:59+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/12/HPE-GettyImages-1356123620-Omicron.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/raas-inhibition-within-intensive-care-reduces-covid-19-mortality/ 2025-01-20T13:35:59+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/12/GettyImages-1255592762.gif-RAAS-covid.gif https://hospitalpharmacyeurope.com/clinical-zones/respiratory/xevudy-sotrovimab-receives-mhra-approval-for-mild-to-moderate-covid-19/ 2025-01-20T13:36:00+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/12/GettyImages-1265198532.gif-covid-infusion.gif https://hospitalpharmacyeurope.com/clinical-zones/respiratory/ciclesonide-equivalent-to-placebo-for-treatment-of-covid-19-symptoms/ 2025-01-20T13:36:01+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/11/GettyImages-1279642091.gif-inhaler-covid.gif https://hospitalpharmacyeurope.com/clinical-zones/respiratory/eye-protection-reduces-covid-19-infection-in-healthcare-workers/ 2025-01-20T13:36:02+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/11/GettyImages-1250357799.gif-eye-protection.gif https://hospitalpharmacyeurope.com/clinical-zones/paediatrics/breast-milk-samples-contain-neutralising-antibodies-to-covid-19/ 2025-01-20T13:36:03+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/11/GettyImages-1219160620.gif-breast-feeding-covid.gif https://hospitalpharmacyeurope.com/clinical-zones/oncology/haematological-cancer-patients-at-higher-risk-of-severe-covid-19-infections-despite-vaccination/ 2025-01-20T13:36:03+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/11/GettyImages-1273004607.gif-blood-cancer-covid.gif https://hospitalpharmacyeurope.com/clinical-zones/respiratory/regdanvimab-recommended-as-a-treatment-for-covid-19-by-the-chmp/ 2025-01-20T13:36:04+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/11/HPE-GettyImages-1302640960-Celltrion.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/fluvoxamine-use-in-patients-at-high-risk-of-covid-19-reduces-time-spent-at-hospital/ 2025-01-20T13:36:05+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/11/GettyImages-1141666933.gif-fluvoxamine.gif https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/statin-use-linked-to-lower-death-rate-in-covid-19/ 2025-01-20T13:36:06+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/10/GettyImages-490758634.jpg-statin-use-COVID-19.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/at-527-fails-to-meet-primary-endpoint-in-mild-to-moderate-covid-19/ 2025-01-20T13:36:07+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/10/GettyImages-1295590006.jpg-AT-527.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/no-reduction-in-cardiopulmonary-events-in-symptomatic-outpatients-with-covid-19/ 2025-01-20T13:36:08+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/10/GettyImages-1035788432.jpg-antithrombotics.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/serum-albumin-levels-an-independent-risk-factor-for-severe-infection-and-mortality-in-covid-19/ 2025-01-20T13:36:09+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/10/HPE-GettyImages-1171634347.jpg-albumin.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/molnupiravir-reduces-covid-19-hospitalisation-by-50/ 2025-01-20T13:36:09+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/10/HPE-GettyImages-1326207484.jpg-covid-pills.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/booster-covid-19-dose-approved-by-ema-28-days-after-second-vaccination/ 2025-01-20T13:36:10+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/08/HPE-GettyImages-1281635877-second-covid-dose.jpg https://hospitalpharmacyeurope.com/clinical-zones/immunology/parental-vaccine-hesitancy-greatest-among-group-most-severely-affected-by-covid-19/ 2025-01-20T13:36:11+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/10/HPE-GettyImages-1325485420.jpg-vaccine-hesitancy.jpg https://hospitalpharmacyeurope.com/clinical-zones/paediatrics/covid-19-severity-in-children-affected-by-similar-factors-to-adults/ 2025-01-20T13:36:12+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/09/HPE-GettyImages-1266353562-covid-children.jpg https://hospitalpharmacyeurope.com/clinical-zones/immunology/covid-19-risk-assessment-tool-predicts-hospital-admission-and-mortality-after-vaccination/ 2025-01-20T13:36:12+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/09/HPEGettyImages-1234710598.jpg-qcovid3.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/lower-risk-of-covid-19-infection-associated-with-higher-diet-quality-score/ 2025-01-20T13:36:13+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/09/HPE-GettyImages-1133754470-diet-and-COVID.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/clotting-disorders-more-likely-after-covid-19-than-vaccination/ 2025-01-20T13:36:14+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/08/HPE-GettyImages-1332113456-clotting-disorder.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/barriers-to-covid-19-mitigation-strategies-in-african-countries/ 2025-01-20T13:36:43+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/08/HPE-GettyImages-1283680241-COVID-Africa.jpg https://hospitalpharmacyeurope.com/clinical-zones/haematology/persistent-endothelial-dysfunction-a-potential-cause-of-long-covid/ 2025-01-20T13:36:44+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/08/HPE-GettyImages-1331672331-long-covid.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/pre-term-births-higher-in-mothers-with-covid-19/ 2025-01-20T13:36:45+00:00 https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/covid-19-is-an-independent-risk-factor-for-myocardial-infarction-and-ischaemic-stroke/ 2025-01-20T13:36:45+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/08/HPE-GettyImages-1217537099-covid-and-myocardial-infarction.jpg https://hospitalpharmacyeurope.com/clinical-zones/immunology/prior-infection-and-full-covid-19-vaccination-boosts-antibody-response/ 2025-01-20T13:36:46+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/08/HPE-GettyImages-130036732-Covid-booster.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/1-in-10-covid-19-infections-were-hospital-acquired/ 2025-01-20T13:36:47+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/08/HPE-GettyImages-481385706-hospital-infections.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/vaccination-not-prior-infection-more-effective-against-covid-19-re-infection/ 2025-01-20T13:36:48+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/08/HPE-GettyImages-1285653618-vaccination-vs-prior-infection.jpg https://hospitalpharmacyeurope.com/clinical-zones/paediatrics/covid-19-of-short-duration-with-low-symptom-burden-in-children/ 2025-01-20T13:36:49+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/08/HPE-GettyImages-1256007848-COVID-children.jpg https://hospitalpharmacyeurope.com/clinical-zones/gastroenterology/new-gastrointestinal-symptoms-in-ibd-linked-with-covid-19/ 2025-01-20T13:36:49+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/08/HPE-GettyImages-921950784-IBD-covid.jpg https://hospitalpharmacyeurope.com/clinical-zones/immunology/covid-delta-variant-viral-load-similar-in-vaccinated-and-unvaccinated/ 2025-01-20T13:36:50+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/08/HPE-GettyImages-1327064910-delta-variant.jpg https://hospitalpharmacyeurope.com/clinical-zones/immunology/second-covid-vaccine-dose-tolerated-after-an-initial-adverse-reaction/ 2025-01-20T13:36:51+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/08/HPE-GettyImages-1281635877-second-covid-dose.jpg https://hospitalpharmacyeurope.com/clinical-zones/mental-health/increased-covid-19-mortality-among-those-with-mental-health-disorders/ 2025-01-20T13:36:52+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/07/HPE-GettyImages-1284032735-mental-health-covid.jpg https://hospitalpharmacyeurope.com/clinical-zones/immunology/study-shows-vaccines-effective-against-covid-19-delta-variant/ 2025-01-20T13:36:53+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/07/HPE-GettyImages-1325066570-delta-variant-study.jpg https://hospitalpharmacyeurope.com/clinical-zones/immunology/extending-covid-19-vaccine-dosing-interval-increases-neutralising-antibodies/ 2025-01-20T13:36:53+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/07/HPE-GettyImages-1218459794-antibody-response-to-vaccine.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/study-concludes-no-mortality-benefit-from-canakinumab-in-hospitalised-covid-19-patients/ 2025-01-20T13:36:54+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/07/HHE-GettyImages-1279978172-canakinumab.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/trial-shows-azithromycin-is-of-no-value-in-mild-to-moderate-covid-19/ 2025-01-20T13:36:55+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/07/HPE-GettyImages-1218112447-Azithrom2.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/covid-19-vaccination-reduces-viral-load-and-duration-of-illness-in-breakthrough-infection/ 2025-01-20T13:36:56+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/07/HPE-GettyImages-1213842966.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/tenofovir-and-emtricitabine-reduce-viral-load-in-mild-covid-19/ 2025-01-20T13:36:57+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/06/GettyImages-1221218166-antiviral.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/oral-anticoagulant-use-appears-to-have-limited-value-in-covid-19/ 2025-01-20T13:36:57+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/07/HPE-GettyImages-588243844.jpg https://hospitalpharmacyeurope.com/clinical-zones/immunology/heterologous-prime-boost-covid-vaccination-schedule-shown-to-be-effective/ 2025-01-20T13:36:58+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/06/HPE-GettyImages-1291748305.jpg https://hospitalpharmacyeurope.com/clinical-zones/rheumatology/inflammatory-rheumatic-diseases-shown-to-worsen-covid-outcomes-in-korean-study/ 2025-01-20T13:36:59+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/06/GettyImages-578291710-auto.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/saliva-more-accurate-for-covid-19-testing-provided-samples-processed-correctly/ 2025-01-20T13:37:00+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/06/HPE-GettyImages-1221348273.jpg https://hospitalpharmacyeurope.com/clinical-zones/mental-health/substantial-psychiatric-morbidity-from-covid-19-identified-in-a-comprehensive-review/ 2025-01-20T13:37:01+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/06/HPE-GettyImages-1302561458.jpg https://hospitalpharmacyeurope.com/clinical-zones/paediatrics/uk-regulator-approves-pfizer-biontech-vaccine-for-12-15-year-olds/ 2025-01-20T13:37:02+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/06/HPE-GettyImages-1307014774.jpg https://hospitalpharmacyeurope.com/in-depth/views/from-physical-to-virtual-to-hybrid/ 2025-01-20T13:37:03+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/06/HPE-GettyImages-1215128301.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/reduced-levels-of-testosterone-in-men-linked-to-worse-outcomes-in-covid-19/ 2025-01-20T13:37:05+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/05/HPE-GettyImages-165629689.jpg https://hospitalpharmacyeurope.com/clinical-zones/paediatrics/only-25-of-children-infected-with-covid-19-display-classic-symptoms/ 2025-01-20T13:37:06+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/06/HPE-GettyImages-1215892007.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/covid-19-vaccines-effective-against-b-1-617-2-variant/ 2025-01-20T13:37:06+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/05/HPE-GettyImages-1304835356.jpg https://hospitalpharmacyeurope.com/clinical-zones/immunology/large-study-indicates-no-benefit-from-colchicine-on-covid-19-mortality/ 2025-01-20T13:37:07+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/05/HPE-GettyImages-952083974.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/specific-covid-19-odours-easily-detected-by-trained-dogs/ 2025-01-20T13:37:08+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/05/HPE-GettyImages-1305955093.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/immune-mediated-inflammatory-diseases-do-not-increase-the-risk-of-covid-19-infection/ 2025-01-20T13:37:09+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/05/HPE-GettyImages-1147468451.jpg https://hospitalpharmacyeurope.com/clinical-zones/immunology/evidence-of-effective-immune-response-in-pregnant-and-lactating-women-after-covid-19-vaccination/ 2025-01-20T13:37:10+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/05/HPE-GettyImages-1306737795.jpg https://hospitalpharmacyeurope.com/clinical-zones/immunology/early-data-suggest-covid-19-vaccines-protect-against-indian-variants-of-concern/ 2025-01-20T13:37:10+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/05/HPE-GettyImages-1214516739.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/covid-19-point-of-care-test-based-on-ace2-provides-results-in-under-5-minutes/ 2025-01-20T13:37:11+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/05/HPE-GettyImages-1217950841.jpg https://hospitalpharmacyeurope.com/clinical-zones/mental-health/pandemic-led-to-deterioration-in-mental-health-of-family-members/ 2025-01-20T13:37:12+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/05/HPE-GettyImages-1226458565.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/lower-level-of-adverse-effects-observed-in-real-world-covid-19-vaccination-study/ 2025-01-20T13:37:13+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/05/HPE-GettyImages-1223042307.jpg https://hospitalpharmacyeurope.com/clinical-zones/immunology/household-transmission-of-covid-19-reduced-by-up-to-50-after-single-vaccine-dose/ 2025-01-20T13:37:14+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/04/HPE-GettyImages-1245228086.jpg https://hospitalpharmacyeurope.com/clinical-zones/immunology/real-world-study-confirms-greater-than-95-protection-from-bnt162b-vaccine/ 2025-01-20T13:37:14+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/05/HPE-GettyImages-1311980507.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/worse-covid-19-related-outcomes-for-ethnic-minority-individuals-confirmed-in-large-uk-study/ 2025-01-20T13:37:15+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/05/HPE-GettyImages-1216445906.jpg https://hospitalpharmacyeurope.com/clinical-zones/mental-health/suicide-rates-not-increased-during-the-uks-first-lockdown/ 2025-01-20T13:37:16+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/04/HPE-GettyImages-1281001620.jpg https://hospitalpharmacyeurope.com/clinical-zones/paediatrics/symptom-based-covid-screening-may-not-be-helpful-in-immunocompromised-children/ 2025-01-20T13:37:17+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/04/HPE-GettyImages-1225442714.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/low-risk-of-covid-re-infection-in-young-seropositive-adults/ 2025-01-20T13:37:18+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/04/HPE-GettyImages-1272358379.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/blood-clots-more-likely-from-covid-19-than-vaccines/ 2025-01-20T13:37:18+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/04/HPE-GettyImages-847473216.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/covid-19-mortality-associated-with-higher-exposure-to-uva/ 2025-01-20T13:37:19+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/04/HPE-GettyImages-1145626113.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/infection-with-covid-19-variant-of-concern-b-1-1-7-does-not-lead-to-more-severe-disease/ 2025-01-20T13:37:20+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/04/HPE-GettyImages-1299802510.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/inhaled-budesonide-reduces-worsening-of-covid-19/ 2025-01-20T13:37:21+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/04/HPE-GettyImages-995968824.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/risk-of-covid-19-infection-higher-from-community-than-workplace-exposure-in-health-workers/ 2025-01-20T13:37:22+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/04/HPE-GettyImages-1211634374.jpg https://hospitalpharmacyeurope.com/clinical-zones/neurology/neurological-or-psychiatric-diagnoses-present-in-a-third-of-patients-after-covid-19-infection/ 2025-01-20T13:37:53+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/04/HPE-GettyImages-1279891636.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/wide-ranging-symptoms-highlighted-by-review-of-post-acute-covid-19/ 2025-01-20T13:37:54+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/03/HPE-GettyImages-1203833696.jpg https://hospitalpharmacyeurope.com/clinical-zones/gastroenterology/treatment-with-infliximab-attenuates-covid-19-antibody-response/ 2025-01-20T13:37:55+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/03/HPE-GettyImages-868766538.jpg https://hospitalpharmacyeurope.com/clinical-zones/immunology/covid-19-antibody-response-in-transplant-patients-low-despite-vaccination/ 2025-01-20T13:37:55+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/03/HPE-GettyImages-1249033934.jpg https://hospitalpharmacyeurope.com/clinical-zones/immunology/does-the-influenza-jab-reduce-the-risk-of-infection-and-symptom-burden-in-covid-19/ 2025-01-20T13:37:56+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/03/HPE-GettyImages-1270968696.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/intermediate-and-standard-dose-prophylactic-anticoagulation-in-covid-19-equivalent/ 2025-01-20T13:37:57+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/03/HPE-GettyImages-1270610024.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/lack-of-knowledge-likely-to-contribute-to-reduced-testing-in-some-covid-symptomatic-individuals/ 2025-01-20T13:37:58+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/03/HPE-GettyImages-1286497230.jpg https://hospitalpharmacyeurope.com/clinical-zones/mental-health/does-an-acute-covid-19-infection-lead-to-depressive-symptoms/ 2025-01-20T13:37:59+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/03/HPE-GettyImages-1061203788.jpg https://hospitalpharmacyeurope.com/clinical-zones/immunology/study-suggests-covid-19-vaccination-reduces-on-ward-transmission-of-the-virus/ 2025-01-20T13:38:00+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/03/HPE-GettyImages-1217100477.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/75-of-us-adults-appear-to-be-at-risk-of-severe-covid-19/ 2025-01-20T13:38:00+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/03/HPE-GettyImages-1217016156.jpg https://hospitalpharmacyeurope.com/clinical-zones/paediatrics/us-study-indicates-low-within-school-transmission-of-covid-19/ 2025-01-20T13:38:01+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/03/HPE-GettyImages-1164371092.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/significantly-higher-risk-of-death-with-uk-covid-19-variant/ 2025-01-20T13:38:02+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/03/HPE-GettyImages-1301873080.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/vitamin-d-deficiency-does-not-impact-on-covid-19-outcomes/ 2025-01-20T13:38:03+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/03/HPE-GettyImages-1217639670.jpg https://hospitalpharmacyeurope.com/clinical-zones/mental-health/increased-anxiety-among-asthmatics-associated-with-disease-worsening-during-covid-19-pandemic/ 2025-01-20T13:38:04+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/02/HPE-GettyImages-1213980253.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/continued-post-covid-19-symptoms-appear-to-last-up-to-six-months-after-infection/ 2025-01-20T13:38:05+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/02/HPE-GettyImages-1206311080.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/covid-symptom-study-suggests-falling-uk-covid-19-infection-rates-are-plateauing/ 2025-01-20T13:38:05+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/02/HPE-GettyImages-1215988312.jpg https://hospitalpharmacyeurope.com/clinical-zones/immunology/study-shows-high-level-of-protection-with-oxford-vaccine-given-12-weeks-apart/ 2025-01-20T13:38:06+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/02/HPE-GettyImages-1288868908.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/largest-rise-in-positive-antibody-tests-among-over-80s-suggests-uk-vaccination-programme-is-working/ 2025-01-20T13:38:07+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/02/HPE-GettyImages-1294865935.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/respiratory-tract-hydration-from-face-masks-may-prevent-covid-19-infection/ 2025-01-20T13:38:08+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/02/HPE-GettyImages-1216315312.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/severe-covid-19-caused-by-second-infection-with-south-african-variant/ 2025-01-20T13:38:09+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/02/HPE-GettyImages-1211349754.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/prophylactic-anticoagulant-use-improves-survival-in-those-with-covid-19/ 2025-01-20T13:38:09+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/02/HPE-GettyImages-995386420.jpg https://hospitalpharmacyeurope.com/clinical-zones/immunology/addition-of-tocilizumab-to-steroids-improves-survival-in-those-hospitalised-with-covid-19/ 2025-01-20T13:38:10+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/02/HPE-GettyImages-1254768480.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/study-shows-supplementing-with-calcifediol-improves-outcomes-in-covid-19/ 2025-01-20T13:38:11+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/02/HPE-GettyImages-1217165490.jpg https://hospitalpharmacyeurope.com/in-depth/views/covid-and-emergency-care-a-view-from-the-uk/ 2025-01-20T13:38:12+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/02/hospital_corridor_GettyImages_524384562_965x500px.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/benefit-of-systemic-corticosteroids-limited-to-only-those-critically-ill-with-covid-19/ 2025-01-20T13:38:12+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/02/HPE-GettyImages-1254958389.jpg https://hospitalpharmacyeurope.com/in-depth/views/examining-the-impact-of-covid-19-on-hospital-provision-in-rheumatology/ 2025-01-20T13:38:13+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/02/covid19_GettyImages_1212956714_965x500px.jpg https://hospitalpharmacyeurope.com/in-depth/views/pharmacists-and-their-crucial-role-in-covid-immunisation/ 2025-01-20T13:38:15+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/02/covid_vaccination_GettyImages_1291768006_965x500px.jpg https://hospitalpharmacyeurope.com/in-depth/views/ivermectin-time-for-action/ 2025-01-20T13:38:16+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/02/HPE-GettyImages-1255914034.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/students-returning-from-university-unlikely-to-cause-rise-in-covid-19-cases/ 2025-01-20T13:38:17+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/02/HPE-GettyImages-1203009042.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/analysis-of-twitter-feeds-revealed-warning-about-covid-19-before-official-recognition/ 2025-01-20T13:38:18+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/02/HPE-GettyImages-1178515839.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/calls-for-harmonising-of-lung-cancer-services-across-europe-after-covid-19/ 2025-01-20T13:38:19+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/01/HPE-GettyImages-1201645724.jpg https://hospitalpharmacyeurope.com/clinical-zones/immunology/data-suggest-janssen-single-dose-vaccine-has-overall-efficacy-of-66/ 2025-01-20T13:38:19+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/01/HPE-GettyImages-1287310354.jpg https://hospitalpharmacyeurope.com/clinical-zones/immunology/moderna-vaccine-provides-immunity-against-both-uk-and-south-african-covid-19-variants/ 2025-01-20T13:38:20+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/01/HPE-GettyImages-1289951048.jpg https://hospitalpharmacyeurope.com/clinical-zones/immunology/current-covid-19-vaccines-may-not-be-effective-against-the-south-african-variant/ 2025-01-20T13:38:21+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/01/HPE-GettyImages-1288583851.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/nervtag-suggests-uk-covid-19-variant-associated-with-higher-mortality/ 2025-01-20T13:38:22+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/01/HPE-GettyImages-1209396374.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/ons-data-suggest-1-in-8-people-in-england-have-already-had-covid-19/ 2025-01-20T13:38:23+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/01/HPE-GettyImages-1296503894.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/dual-mab-therapy-reduces-viral-load-in-patients-with-mild-to-moderate-covid-19/ 2025-01-20T13:38:23+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/01/HPE-GettyImages-173504558.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/use-of-metformin-in-diabetics-appears-to-be-protective-against-covid-19-related-mortality/ 2025-01-20T13:38:24+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/01/HPE-GettyImages-455196433.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/high-levels-of-covid-19-found-in-hospital-air-samples-but-few-viable-viruses/ 2025-01-20T13:38:25+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/01/HPE-GettyImages-1215011227.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/both-tocilizumab-and-sarilumab-improve-survival-among-those-critically-ill-with-covid-19/ 2025-01-20T13:38:26+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/01/HPE-GettyImages-1219502481.jpg https://hospitalpharmacyeurope.com/clinical-zones/immunology/bnt162b2-vaccine-appears-effective-against-n501y-mutant-strain-of-covid-19/ 2025-01-20T13:38:26+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/01/HPE-GettyImages-1290738192.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/mutation-in-covid-19-variant-leads-to-greater-binding-to-ace2/ 2025-01-20T13:38:27+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/12/HPE-GettyImages-1292396644.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/nearly-a-third-of-those-discharged-from-hospital-after-covid-19-readmitted-within-60-days/ 2025-01-20T13:38:28+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/12/HPE-GettyImages-1255849314.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/does-covid-19-lead-to-ocular-symptoms/ 2025-01-20T13:38:29+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/12/HPE-GettyImages-1215424896.jpg https://hospitalpharmacyeurope.com/clinical-zones/immunology/study-confirms-95-efficacy-claim-for-covid-19-vaccine/ 2025-01-20T13:38:30+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/12/HPE-GettyImages-1250100089.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/altered-mentation-in-covid-19-patients-leads-to-higher-in-hospital-mortality/ 2025-01-20T13:38:30+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/01/HPE-GettyImages-1203733750.jpg https://hospitalpharmacyeurope.com/clinical-zones/immunology/20-of-people-across-the-world-would-refuse-a-covid-19-vaccine/ 2025-01-20T13:38:31+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/12/HPE-GettyImages-1258304128.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/nutritional-supplements-possibly-beneficial-in-covid-19/ 2025-01-20T13:38:32+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/12/HPE-GettyImages-183367047.jpg https://hospitalpharmacyeurope.com/clinical-zones/paediatrics/differences-in-immune-and-clotting-functioning-may-account-for-less-severe-covid-19-in-children/ 2025-01-20T13:38:33+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/12/HPE-GettyImages-1213090147.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/low-bmi-a-risk-factor-for-death-in-covid-19/ 2025-01-20T13:39:54+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/12/HPE-GettyImages-926092320.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/hospital-to-community-pharmacy-medication-delivery-service-valued-by-patients/ 2025-01-20T13:39:55+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/12/HPE-GettyImages-523174802.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/covid-19-mutations-not-associated-with-an-increased-risk-of-transmission/ 2025-01-20T13:39:56+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/12/HPE-GettyImages-1218863475.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/latest-react-1-study-shows-covid-19-rates-falling/ 2025-01-20T13:39:57+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/11/HPE-GettyImages-1213712504.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/mouthwashes-eradicate-covid-19-infectivity/ 2025-01-20T13:39:58+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/11/HPE-GettyImages-453443007.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/protective-role-of-face-masks-against-covid-19-still-unclear/ 2025-01-20T13:39:58+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/11/HPE-GettyImages-1252763475.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/prolonged-viral-shedding-not-associated-with-viable-covid-19-virus/ 2025-01-20T13:39:59+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/11/HPE-GettyImages-1219421910.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/analysis-confirms-increased-risk-of-covid-19-among-bame-individuals/ 2025-01-20T13:40:00+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/11/HPE-GettyImages-1214385164.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/medicines-management-challenges-in-a-cardiothoracic-centre-during-covid-19/ 2025-01-20T13:40:01+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/11/Lungs_GettyImages_922879348_965x500px.jpg https://hospitalpharmacyeurope.com/in-depth/views/covid-19-and-opportunities-for-the-future/ 2025-01-20T13:40:03+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/11/Tiene_Bauters_965x500px.jpg https://hospitalpharmacyeurope.com/in-depth/views/is-14-days-of-quarantine-after-returning-from-abroad-too-long/ 2025-01-20T13:40:03+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/11/HPE-GettyImages-1203956356.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/rapid-covid-19-diagnostic-can-help-differentiate-between-viral-infections/ 2025-01-20T13:40:05+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/11/HPE-GettyImages-1202826109.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/aspirin-associated-with-improved-outcomes-for-patients-with-covid-19/ 2025-01-20T13:40:06+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/10/HPE-GettyImages-1213090148.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/fda-approves-remdesivir-for-covid-19/ 2025-01-20T13:40:07+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/10/HPE-GettyImages-1223960456.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/plasma-therapy-ineffective-for-covid-19/ 2025-01-20T13:40:09+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/10/HPE-GettyImages-1219326221.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/latest-react-1-data-show-rapid-growth-in-covid-19/ 2025-01-20T13:40:09+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/10/HPE-GettyImages-1213578032.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/analysis-reveals-the-duration-of-viral-shedding-in-covid-19/ 2025-01-20T13:40:10+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/10/HPE-GettyImages-1215185862.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/latest-case-of-covid-19-re-infection-due-to-a-different-strain/ 2025-01-20T13:40:11+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/10/HPE-GettyImages-1267549078.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/the-flood-of-substandard-covid-19-research-is-cause-for-concern/ 2025-01-20T13:40:12+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/10/HPE-GettyImages-1214333918.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/covid-19-survives-on-skin-surfaces-but-quickly-removed-by-washing/ 2025-01-20T13:40:13+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/10/HPE-GettyImages-1211201498.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/ai-predicts-covid-19-status-faster-than-a-pcr-test/ 2025-01-20T13:40:13+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/10/HPE-GettyImages-1215976965.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/new-study-suggests-covid-19-infection-rates-are-falling-in-the-uk/ 2025-01-20T13:40:14+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/10/HPE-GettyImages-1200769096.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/short-term-use-of-hydroxychloroquine-safe-for-patients-with-covid-19/ 2025-01-20T13:40:15+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/10/HPE-GettyImages-1214912928.jpg https://hospitalpharmacyeurope.com/clinical-zones/paediatrics/new-study-analyses-immune-response-to-covid-19-in-young-people/ 2025-01-20T13:40:16+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/09/HPE-GettyImages-1214529723.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/nosocomial-infection-of-covid-19-is-rare-study-shows/ 2025-01-20T13:40:17+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/09/HPE-GettyImages-1217762157.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/arthritic-covid-1-patients-taking-steroids-have-worse-outcomes/ 2025-01-20T13:40:17+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/09/HPE-GettyImages-1202030778.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/liver-transplant-does-not-appear-to-increase-risk-of-mortality-in-covid-19/ 2025-01-20T13:40:18+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/09/HPE-GettyImages-1089660444.jpg https://hospitalpharmacyeurope.com/clinical-zones/mental-health/study-shows-that-burden-of-depression-in-some-adults-increased-during-covid-19/ 2025-01-20T13:40:19+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/09/HPE-GettyImages-1199606087.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/current-covid-social-distancing-guidance-might-not-be-enough/ 2025-01-20T13:40:20+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/09/HPE-GettyImages-1217399701.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/re-infection-with-covid-19-is-a-cause-for-concern/ 2025-01-20T13:40:20+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/09/HPE-GettyImages-1212590125.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/covid-19-antibody-levels-vary-considerably-in-those-with-mild-disease/ 2025-01-20T13:40:22+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/08/HPE-GettyImages-1223999391.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/contact-tracing-apps-unlikely-to-reduce-the-spread-of-covid-19/ 2025-01-20T13:40:23+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/08/HPE-GettyImages-1225654670.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/public-health-england-modifies-definition-of-covid-19-related-deaths/ 2025-01-20T13:40:24+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/08/HPE-GettyImages-1213511484.jpg https://hospitalpharmacyeurope.com/clinical-zones/paediatrics/school-children-could-play-a-role-in-spreading-covid-19/ 2025-01-20T13:40:24+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/08/HPE-GettyImages-517687348.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/large-scale-population-wide-testing-needed-to-prevent-a-second-covid-19-wave/ 2025-01-20T13:40:25+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/08/HPE-GettyImages-1223850843.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/less-than-a-third-of-current-covid-19-studies-are-of-high-quality/ 2025-01-20T13:40:26+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/08/HPE-GettyImages-1214095767.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/critical-care-guidelines-inconsistent-with-who-recommendations/ 2025-01-20T13:40:27+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/08/HPE-GettyImages-1254958416.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/study-suggests-breathing-and-coughing-can-release-large-amounts-of-covid-19/ 2025-01-20T13:40:27+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/08/HPE-GettyImages-1201363459-1.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/two-rapid-coronavirus-tests-rolled-out-in-the-uk/ 2025-01-20T13:40:28+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/08/HPE-GettyImages-1213186471.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/arranging-planned-care-in-hospitals-and-diagnostic-services-nice-guideline-summary/ 2025-01-20T13:40:29+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/07/HPE-GettyImages-1082065574.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/blood-test-detects-covid-19-antibodies-in-20-minutes/ 2025-01-20T13:40:30+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/07/HPE-GettyImages-1216431099.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/study-helps-explain-how-covid-19-causes-anosmia/ 2025-01-20T13:40:31+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/07/HPE-GettyImages-1211174165.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/model-to-assess-critical-care-drug-requirements-likely-to-be-useful-across-other-therapeutic-areas/ 2025-01-20T13:40:32+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/07/HPE-GettyImages-1220396380.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/some-statistics-on-covid-19-related-deaths-are-likely-to-have-been-over-reported/ 2025-01-20T13:40:33+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/07/HPE-GettyImages-1209311097.jpg https://hospitalpharmacyeurope.com/clinical-zones/immunology/oxford-vaccine-shows-boosts-antibody-response/ 2025-01-20T13:40:33+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/07/HPE-GettyImages-1214508941.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/do-neutralising-antibodies-to-covid-19-decline-over-time/ 2025-01-20T13:43:44+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/07/HPE-GettyImages-1217007503.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/covid-19-symptoms-persist-after-acute-infection/ 2025-01-20T13:43:45+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/07/HPE-GettyImages-1212826378.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/study-reviews-and-offers-management-advice-for-extrapulmonary-effects-of-covid-19/ 2025-01-20T13:43:46+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/07/HPE-GettyImages-1209209417.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/are-patients-with-asthma-protected-against-covid-19/ 2025-01-20T13:43:47+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/07/HPE-GettyImages-1208822886.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/covid-19-cases-declining-but-levelling-according-to-survey/ 2025-01-20T13:43:48+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/07/HPE-GettyImages-1218825044.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/renal-transplantation-nice-covid-19-rapid-guideline-summary/ 2025-01-20T13:43:51+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/06/HPE-GettyImages-650717510.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/low-cost-dexamethasone-reduces-death-by-up-to-one-third-in-hospitalised-patients-with-severe-respiratory-complications-of-covid-19/ 2025-01-20T13:43:52+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/06/HPE-GettyImages-182835375.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/global-oncology-pharmacists-face-restricted-access-to-essential-ppe-items/ 2025-01-20T13:43:56+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/06/HPE-GettyImages-1203224882.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/are-smokers-protected-from-covid-19/ 2025-01-20T13:43:57+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/05/HPE-GettyImages-909619156.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/loss-of-smell-added-to-list-of-covid-19-symptoms/ 2025-01-20T13:43:59+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/05/HPE-GettyImages-165765009.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/are-inhaled-corticosteroids-safe-in-those-with-covid-19/ 2025-01-20T13:43:59+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/05/HPE-GettyImages-1203426591.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/covid-19-rapid-guideline-summary-chronic-kidney-disease/ 2025-01-20T13:44:00+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/05/HHE-GettyImages-1191189985.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/ons-infection-survey-suggests-nearly-150000-have-covid-19/ 2025-01-20T13:44:01+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/05/HPE-GettyImages-1213710695.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/indomethacin-has-a-positive-impact-on-symptoms-of-covid-19/ 2025-01-20T13:44:02+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/05/HPE-GettyImages-1209311066.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/which-covid-19-patients-develop-critical-illness/ 2025-01-20T13:44:02+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/05/HPE-GettyImages-1213600952.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/bame-patients-more-likely-to-die-after-covid-19-infection-but-why/ 2025-01-20T13:44:03+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/05/HPE-GettyImages-1214140548.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/acute-kidney-injury-in-hospital-covid-19-rapid-guideline-summary/ 2025-01-20T13:44:04+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/05/HPE-GettyImages-1206172569.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/chloroquine-and-patients-with-severe-covid-19-reviewing-the-evidence/ 2025-01-20T13:44:05+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/05/HPE-GettyImages-1214966670.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/american-gastroenterological-society-publishes-expert-recommendations-in-management-of-patients-with-covid-19/ 2025-01-20T13:44:06+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/05/HPE-GettyImages-1062628186.jpg https://hospitalpharmacyeurope.com/clinical-zones/paediatrics/covid-19-rapid-guideline-summary-immunocompromised-children-and-young-people/ 2025-01-20T13:44:08+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/05/HPE-GettyImages-1206925198.jpg https://hospitalpharmacyeurope.com/clinical-zones/paediatrics/managing-childhood-allergies-and-immunodeficiencies-during-covid-19-an-eacci-statement/ 2025-01-20T13:44:09+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/04/HPE-GettyImages-1207724800.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/analysis-shows-that-sars-cov-2-has-not-mutated/ 2025-01-20T13:44:09+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/05/HPE-GettyImages-1217807157.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/an-aria-eaaci-statement-handling-allergen-immunotherapy-during-the-pandemic/ 2025-01-20T13:44:10+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/04/HPE-GettyImages-831326394.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/government-begins-large-scale-testing-to-track-covid-19/ 2025-01-20T13:44:12+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/04/HPE-GettyImages-1211156080.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/is-covid-19-still-evolving/ 2025-01-20T13:44:13+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/04/HPE-GettyImages-1210184156.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/which-groups-of-patients-are-at-highest-risk-from-covid-19-infection/ 2025-01-20T13:44:13+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/04/HPE-GettyImages-1209682211.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/acute-myocardial-injury-covid-rapid-guideline-summary/ 2025-01-20T13:44:15+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/04/HPE-GettyImages-1031840682.jpg https://hospitalpharmacyeurope.com/clinical-zones/immunology/covid-19-vaccine-trial-to-start/ 2025-01-20T13:44:16+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/04/HPE-GettyImages-1205534989.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/were-they-ready-an-analysis-of-us-actions-and-attitudes-to-the-covid-19-outbreak/ 2025-01-20T13:44:18+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/04/HPE-GettyImages-1178381070.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/acute-use-of-nsaids-for-people-with-or-at-risk-of-covid-19-nice-rapid-evidence-summary/ 2025-01-20T13:44:19+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/04/HPE-GettyImages-898830620.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/covid-19-rapid-guideline-summary-cystic-fibrosis/ 2025-01-20T13:44:19+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/04/HPE-GettyImages-1205199983.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/severe-asthma-covid-19-rapid-guideline-summary/ 2025-01-20T13:44:21+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/04/HPE-GettyImages-931423088.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/delivery-of-systemic-anticancer-treatments-nice-covid-19-rapid-guideline-summary/ 2025-01-20T13:44:22+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/04/HPE-GettyImages-172768053.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/figo-guidance-on-covid-19-during-pregnancy-and-puerperium-a-summary/ 2025-01-20T13:44:22+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/04/HPE-GettyImages-1004788986.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/protection-from-falsified-medical-products-during-covid-19/ 2025-01-20T13:44:23+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/04/HPE-GettyImages-914789708.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/commentary-what-the-italians-learnt-from-the-covid-19-outbreak/ 2025-01-20T13:44:56+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/04/HPE-GettyImages-1212402004.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/commentary-pharmacy-services-during-covid-19/ 2025-01-20T13:44:57+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/04/HPE-GettyImages-1206465031.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/shorter-course-radiotherapy-recommended-for-bowel-cancer-during-the-pandemic/ 2025-01-20T13:44:58+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/04/HPE-GettyImages-683401446.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/commentary-perioperative-management-of-patients-with-covid-19/ 2025-01-20T13:44:59+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/04/HPE-GettyImages-975943970.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/managing-critically-ill-adults-with-covid-19-surviving-sepsis-campaign-guidelines/ 2025-01-20T13:45:00+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/04/HPE-GettyImages-994999344.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/queens-university-belfast-leading-cell-therapy-clinical-trial-in-covid-19-patients/ 2025-01-20T13:45:00+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/04/HPE-GettyImages-157741127.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/commentary-managing-the-airways-in-patients-with-covid-19-consensus-guidelines/ 2025-01-20T13:45:01+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/04/HPE-GettyImages-1135238413.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/commentary-covid-19-and-the-heart-another-potential-complication/ 2025-01-20T13:45:02+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/04/HPE-GettyImages-1072031934.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/commentary-app-tracking-for-covid-19/ 2025-01-20T13:45:03+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/04/HPE-GettyImages-1213507300.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/nice-guideline-summary-dialysis-service-delivery-during-the-covid-19-pandemic/ 2025-01-20T13:45:04+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/04/HPE-GettyImages-1125420840.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/ai-tool-accurately-predicts-development-of-severe-respiratory-disease-in-covid-19-patients/ 2025-01-20T13:45:05+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/04/HPE-GettyImages-878843918.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/using-a-mobile-app-to-trace-close-proximity-coronavirus-contacts/ 2025-01-20T13:45:06+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/03/HPE-GettyImages-1206802425.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/identifying-which-medications-are-safe-to-use-in-covid-19-patients/ 2025-01-20T13:45:07+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/03/HHE-GettyImages-1140100119.jpg https://hospitalpharmacyeurope.com/clinical-zones/mental-health/protecting-young-peoples-mental-health-during-the-covid-19-crisis/ 2025-01-20T13:45:08+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/03/HPE-GettyImages-540961086.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/nice-publishes-first-three-rapid-covid-19-guidelines/ 2025-01-20T13:45:09+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/03/HPE-GettyImages-1206405721.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/worse-outcomes-for-covid-19-patients-with-cv-disease/ 2025-01-20T13:45:09+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/03/HPE-GettyImages-154890609.jpg https://hospitalpharmacyeurope.com/clinical-zones/respiratory/nice-developing-a-series-of-rapid-covid-19-guidelines/ 2025-01-20T13:45:10+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/03/HPE-GettyImages-1208315128.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/is-diabetes-care-in-the-uk-adequate/ 2025-01-20T13:47:13+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2023/05/Is-diabetes-care-in-the-Uk-adequate.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/semaglutide-reduces-10-year-risk-of-type-2-diabetes-in-obese-patients/ 2025-01-20T13:47:14+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/09/Semaglutide-reduces-10-year-risk-of-type-2-diabetes-in-obese-patients.jpg https://hospitalpharmacyeurope.com/clinical-zones/oestrogen-mono-therapy-associated-with-reduced-mortality-risk-in-over-65s/ 2025-01-20T13:47:15+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2022/07/Oestrogen-mono-therapy-associated-with-reduced-mortality-risk-in-over-65s.jpg https://hospitalpharmacyeurope.com/clinical-zones/paediatrics/diabetic-associated-ocular-problem-risk-higher-in-children-with-type-2-than-type-1-disease/ 2025-01-20T13:47:16+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/12/GettyImages-629802096.gif-eye-screening.gif https://hospitalpharmacyeurope.com/clinical-zones/semaglutide-superior-to-liraglutide-for-weight-loss-in-non-diabetics/ 2025-01-20T13:47:16+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/11/GettyImages-1347115960.gif-obesity.gif https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/vled-and-formula-meal-replacement-diets-best-for-weight-loss-in-type-2-diabetes/ 2025-01-20T13:47:18+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/11/GettyImages-1143073058.gif-diet-and-type-2-diabetes.gif https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/intermittent-very-low-calorie-diet-leads-to-remission-in-nearly-a-third-of-type-2-diabetics/ 2025-01-20T13:47:19+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/09/HPE-GettyImages-1284690585-intermittent-VLCD.jpg https://hospitalpharmacyeurope.com/clinical-zones/paediatrics/greater-risk-of-high-refractive-error-in-children-of-diabetic-mothers/ 2025-01-20T13:47:19+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/08/HPE-GettyImages-1153643835-highrefractive-errors.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/adding-a-ppi-improves-glycaemic-control-in-diabetics/ 2025-01-20T13:47:20+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/06/GettyImages-1145647406-diabetes.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/study-shows-increased-fruit-intake-associated-with-lower-risk-of-diabetes/ 2025-01-20T13:47:21+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/06/HPE-GettyImages-1204015130.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/study-indicates-that-levels-of-glycaemic-control-only-achieved-by-half-of-diabetic-patients/ 2025-01-20T13:47:22+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/06/HPE-GettyImages-826311872.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/study-shows-many-of-those-with-diabetes-turn-to-complementary-medicine/ 2025-01-20T13:47:23+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/03/HPE-GettyImages-1210564050.jpg https://hospitalpharmacyeurope.com/clinical-zones/non-invasive-retinal-imaging-for-assessment-of-cognitive-dysfunction-in-type-1-diabetes/ 2025-01-20T13:47:23+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/02/HPE-GettyImages-941484306.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/bimagrumab-reduces-fat-mass-in-obese-type-2-diabetic-patients/ 2025-01-20T13:47:24+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2021/01/HPE-GettyImages-658368010.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/better-glucose-control-improves-cognitive-function-in-type-2-diabetes/ 2025-01-20T13:47:25+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/10/HPE-GettyImages-1124485411.jpg https://hospitalpharmacyeurope.com/clinical-zones/allopurinol-does-not-preserve-kidney-function-in-type-1-diabetes/ 2025-01-20T13:47:26+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/06/HPE-GettyImages-1089689202.jpg https://hospitalpharmacyeurope.com/clinical-zones/tresiba-demonstrated-lower-day-to-day-and-within-day-variability-in-glucose-lowering-effect-compared-with-insulin-glargine-u300/ 2025-01-20T13:47:27+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/05/Diabetes-2.jpg https://hospitalpharmacyeurope.com/clinical-zones/new-guidelines-will-improve-treatment-for-patients-with-hyperthyroidism/ 2025-01-20T13:47:27+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2020/01/HPE-GettyImages-1194707415.jpg https://hospitalpharmacyeurope.com/news/diabetes-prescriptions-cost-nhs-over-1bn-a-year-data-reveals/ 2025-01-20T13:47:28+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/Diabetes-2.jpg https://hospitalpharmacyeurope.com/clinical-zones/managing-chronic-hypoparathyroidism/ 2025-01-20T13:47:29+00:00 https://hospitalpharmacyeurope.com/clinical-zones/childhood-obesity-branded-everyones-business-by-new-report/ 2025-01-20T13:47:30+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2018/06/obese_boy_411x220px.jpeg https://hospitalpharmacyeurope.com/clinical-zones/paediatrics/novorapid-receives-positive-chmp-opinion-for-extended-use-in-children-as-young-as-one-year-old/ 2025-01-20T13:47:30+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2017/05/Diabetes-2.jpg https://hospitalpharmacyeurope.com/clinical-zones/health-related-quality-of-life-and-hormone-replacement-therapy/ 2025-01-20T13:47:32+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2018/02/Storage-1.jpg https://hospitalpharmacyeurope.com/clinical-zones/pasireotide-lar-beats-octreotide-im-in-acromegaly/ 2025-01-20T13:47:32+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2012/05/Endocrinology_thyroid.jpg https://hospitalpharmacyeurope.com/clinical-zones/krystexxa-available-in-eu-for-refractory-chronic-gout/ 2025-01-20T13:47:33+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2012/05/Endocrinology_thyroid.jpg https://hospitalpharmacyeurope.com/clinical-zones/pasireotide-shows-potential-for-cushings-disease/ 2025-01-20T13:47:34+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2012/05/Endocrinology_thyroid.jpg https://hospitalpharmacyeurope.com/clinical-zones/cfs-drug-shows-promise-at-phase-3/ 2025-01-20T13:47:35+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2018/01/mental-health-965x500-copy.jpg https://hospitalpharmacyeurope.com/clinical-zones/phase-iii-first-for-cushings-disease-drug/ 2025-01-20T13:47:36+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2012/05/Endocrinology_thyroid.jpg https://hospitalpharmacyeurope.com/clinical-zones/ema-recommends-pasireotide-for-cushings-disease/ 2025-01-20T13:47:37+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2012/05/Endocrinology_thyroid.jpg https://hospitalpharmacyeurope.com/clinical-zones/levothyroxine-sodium-for-injection-fda-approval-announced/ 2025-01-20T13:47:38+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2018/02/Endocrinology_thyroid.jpg https://hospitalpharmacyeurope.com/clinical-zones/oxytocin-positively-affects-prader-willi-syndrome/ 2025-01-20T13:47:38+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2012/05/Endocrinology_thyroid.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/phase-ii-study-shows-objective-response-rate-in-thyroid-cancer/ 2025-01-20T13:47:39+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/Endocrinology_thyroid.jpg https://hospitalpharmacyeurope.com/clinical-zones/thyroid-medication-warning-issued/ 2025-01-20T13:47:40+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/06/Endocrinology_thyroid.jpg https://hospitalpharmacyeurope.com/clinical-zones/follicle-stimulating-hormone-trial-starts/ 2025-01-20T13:47:40+00:00 https://hospitalpharmacyeurope.com/clinical-zones/oncology/thyroid-cancer-drug-approved/ 2025-01-20T13:47:41+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/08/Oncology-1.jpg https://hospitalpharmacyeurope.com/clinical-zones/drug-combination-beats-obesity/ 2025-01-20T13:47:42+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2002/03/obese-boy-965x500.jpg https://hospitalpharmacyeurope.com/clinical-zones/cardiovascular-medicine/male-hormone-linked-to-heart-deaths/ 2025-01-20T13:47:43+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2018/02/Endocrinology_thyroid.jpg https://hospitalpharmacyeurope.com/clinical-zones/som230-is-first-medical-therapy-to-show-efficacy-in-a-phase-iii-trial-in-cushings-disease/ 2025-01-20T13:47:44+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2012/05/Endocrinology_thyroid.jpg https://hospitalpharmacyeurope.com/clinical-zones/european-commission-grants-marketing-authorisation-for-vpriv/ 2025-01-20T13:47:45+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2002/09/HPE-european-community.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/vandetanib-shows-positive-results/ 2025-01-20T13:47:45+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/08/Oncology-1.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/treating-the-hyperthyroid-patient-with-radioiodine/ 2025-01-20T13:47:46+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2012/05/Endocrinology_thyroid.jpg https://hospitalpharmacyeurope.com/clinical-zones/fda-calls-for-conflict-inquiry/ 2025-01-20T13:47:47+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2012/05/Endocrinology_thyroid.jpg https://hospitalpharmacyeurope.com/clinical-zones/shire-receives-chmp-positive-opinion-for-vpriv-the-treatment-of-type-1-gaucher-disease/ 2025-01-20T13:47:48+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2012/05/Endocrinology_thyroid.jpg https://hospitalpharmacyeurope.com/clinical-zones/gaucher-fighting-drug-for-europe/ 2025-01-20T13:47:49+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2012/05/Endocrinology_thyroid.jpg https://hospitalpharmacyeurope.com/clinical-zones/results-of-zeta-study-presented-at-asco/ 2025-01-20T13:47:49+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2018/02/Endocrinology_thyroid.jpg https://hospitalpharmacyeurope.com/clinical-zones/shire-to-present-important-study-findings-for-gaucher-disease-treatment/ 2025-01-20T13:47:50+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2012/05/Endocrinology_thyroid.jpg https://hospitalpharmacyeurope.com/clinical-zones/mental-health/stress-drugs-must-work-with-body/ 2025-01-20T13:47:51+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2012/05/Endocrinology_thyroid.jpg https://hospitalpharmacyeurope.com/clinical-zones/hra-pharma-expands-to-spain-and-launches-ellaone/ 2025-01-20T13:47:52+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2012/05/Endocrinology_thyroid.jpg https://hospitalpharmacyeurope.com/clinical-zones/shire-bids-for-gaucher-approval/ 2025-01-20T13:47:53+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2012/05/Endocrinology_thyroid.jpg https://hospitalpharmacyeurope.com/clinical-zones/oncology/degarelix-for-the-treatment-of-hormone-sensitive-prostate-cancer/ 2025-01-20T13:47:53+00:00 https://hospitalpharmacyeurope.com/wp-content/uploads/2011/08/Oncology-1.jpg